Title,Authors,Platform,Cited_url,Cited_count,Year
Signatures of mutational processes in human cancer,"LB Alexandrov, S Nik-Zainal, DC Wedge, SAJR Aparicio, S Behjati, ...","Nature 500 (7463), 415",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2441388929530655054,4671,2013
"The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups","C Curtis, SP Shah, SF Chin, G Turashvili, OM Rueda, MJ Dunning, ...","Nature 486 (7403), 346",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18325413610630498471,3207,2012
Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer,"MF Fraga, E Ballestar, A Villar-Garea, M Boix-Chornet, J Espada, ...","Nature genetics 37 (4), 391",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5430545135480728108,1803,2005
The clonal and mutational evolution spectrum of primary triple-negative breast cancers,"SP Shah, A Roth, R Goya, A Oloumi, G Ha, Y Zhao, G Turashvili, J Ding, ...","Nature 486 (7403), 395",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13780020019361410859,1489,2012
International network of cancer genome projects,International Cancer Genome Consortium,"Nature 464 (7291), 993",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7145450135340795644,1482,2010
Analysis of circulating tumor DNA to monitor metastatic breast cancer,"SJ Dawson, DWY Tsui, M Murtaza, H Biggs, OM Rueda, SF Chin, ...","New England Journal of Medicine 368 (13), 1199-1209",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9705244202720370300,1458,2013
Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma,"C Caldas, SA Hahn, LT Da Costa, MS Redston, M Schutte, AB Seymour, ...","Nature genetics 8 (1), 27","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16963821236439127991,14229183098822328758",1366,1994
The landscape of cancer genes and mutational processes in breast cancer,"PJ Stephens, PS Tarpey, H Davies, P Van Loo, C Greenman, DC Wedge, ...","Nature 486 (7403), 400",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3798797558700113700,1338,2012
Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA,"M Murtaza, SJ Dawson, DWY Tsui, D Gale, T Forshew, AM Piskorz, ...","Nature 497 (7447), 108",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3196447526721269660,1252,2013
Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution,"SP Shah, RD Morin, J Khattra, L Prentice, T Pugh, A Burleigh, A Delaney, ...","Nature 461 (7265), 809",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16389167554721749545,1100,2009
MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype,"C Blenkiron, LD Goldstein, NP Thorne, I Spiteri, SF Chin, MJ Dunning, ...","Genome biology 8 (10), R214",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17600291116211245088,1003,2007
Molecular classification and molecular forecasting of breast cancer: ready for clinical application?,"JD Brenton, LA Carey, AA Ahmed, C Caldas","Journal of clinical oncology 23 (29), 7350-7360",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6166629541870891725,994,2005
Genetic unmasking of an epigenetically silenced microRNA in human cancer cells,"A Lujambio, S Ropero, E Ballestar, MF Fraga, C Cerrato, F Setién, ...","Cancer research 67 (4), 1424-1429",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10457527738336206202,947,2007
Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA,"T Forshew, M Murtaza, C Parkinson, D Gale, DWY Tsui, F Kaper, ...","Science translational medicine 4 (136), 136ra68-136ra68",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3714184042259262692,886,2012
Landscape of somatic mutations in 560 breast cancer whole-genome sequences,"S Nik-Zainal, H Davies, J Staaf, M Ramakrishna, D Glodzik, X Zou, ...","Nature 534 (7605), 47",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18333923509031783878,810,2016
"Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 …","FM Blows, KE Driver, MK Schmidt, A Broeks, FE Van Leeuwen, ...","PLoS medicine 7 (5), e1000279","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10396345045842285233,13667778421349246018",805,2010
Differential oestrogen receptor binding is associated with clinical outcome in breast cancer,"CS Ross-Innes, R Stark, AE Teschendorff, KA Holmes, HR Ali, ...","Nature 481 (7381), 389",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17548859594107410025,791,2012
 and Interleukin 1 Genotyping: An Opportunity to Identify High-Risk Individuals for Gastric Carcinoma,"C Figueiredo, JC Machado, P Pharoah, R Seruca, S Sousa, R Carvalho, ...","Journal of the National Cancer Institute 94 (22), 1680-1687",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16401925795958111918,703,2002
Patient-derived xenograft models: an emerging platform for translational cancer research,"M Hidalgo, F Amant, AV Biankin, E Budinská, AT Byrne, C Caldas, ...","Cancer discovery 4 (9), 998-1013",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13137393281630051373,694,2014
Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families,"PDP Pharoah, P Guilford, C Caldas, ...","Gastroenterology 121 (6), 1348-1353",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18385271614626718113,673,2001
Familial gastric cancer: overview and guidelines for management,"C Caldas, F Carneiro, HT Lynch, J Yokota, GL Wiesner, SM Powell, ...","Journal of medical genetics 36 (12), 873-880",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16532701614596505768,662,1999
Liquid biopsies come of age: towards implementation of circulating tumour DNA,"JCM Wan, C Massie, J Garcia-Corbacho, F Mouliere, JD Brenton, ...","Nature Reviews Cancer 17 (4), 223",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9581370885907569537,639,2017
Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research,"RC Fitzgerald, R Hardwick, D Huntsman, F Carneiro, P Guilford, V Blair, ...","Journal of medical genetics 47 (7), 436-444",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11020925443911419155,618,2010
"Systematic comparison of microarray profiling, real-time PCR, and next-generation sequencing technologies for measuring differential microRNA expression","A Git, H Dvinge, M Salmon-Divon, M Osborne, C Kutter, J Hadfield, ...","Rna 16 (5), 991-1006",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11524677199786616167,614,2010
Mutations truncating the EP300 acetylase in human cancers,"SA Gayther, SJ Batley, L Linger, A Bannister, K Thorpe, SF Chin, Y Daigo, ...","Nature genetics 24 (3), 300",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=272449030207133300,609,2000
A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma,"JC Machado, C Figueiredo, P Canedo, P Pharoah, R Carvalho, S Nabais, ...","Gastroenterology 125 (2), 364-371",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4264067823288442363,583,2003
p300/CBP and cancer,"NG Iyer, H Özdag, C Caldas","Oncogene 23 (24), 4225",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5213314583838219043,560,2004
Driver mutations in ,"AA Ahmed, D Etemadmoghadam, J Temple, AG Lynch, M Riad, ...","The Journal of pathology 221 (1), 49-56",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=557240496509889815,548,2010
MicroRNA—implications for cancer,"S Sassen, EA Miska, C Caldas","Virchows Archiv 452 (1), 1-10",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13447568218513119131,531,2008
p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions,"MS Redston, C Caldas, AB Seymour, RH Hruban, L Da Costa, CJ Yeo, ...","Cancer research 54 (11), 3025-3033",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12170982787358842634,524,1994
Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma,"JC Machado, P Pharoah, S Sousa, R Carvalho, C Oliveira, C Figueiredo, ...","Gastroenterology 121 (4), 823-829",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12265267092750147884,519,2001
Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data,"FC Bidard, DJ Peeters, T Fehm, F Nolé, R Gisbert-Criado, D Mavroudis, ...","The lancet oncology 15 (4), 406-414",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9938254751689664070,510,2014
Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis,"J Stingl, C Caldas","Nature Reviews Cancer 7 (10), 791",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9306544337521631052,491,2007
"The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes","B Pereira, SF Chin, OM Rueda, HKM Vollan, E Provenzano, HA Bardwell, ...","Nature communications 7, 11479","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17570897177527480832,8629088782455610129",482,2016
An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer,"AE Teschendorff, A Miremadi, SE Pinder, IO Ellis, C Caldas","Genome biology 8 (8), R157",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5744376760534413815,472,2007
Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia,"C Caldas, SA Hahn, RH Hruban, MS Redston, CJ Yeo, SE Kern","Cancer research 54 (13), 3568-3573",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1607352258227519835,460,1994
"Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations","DG Huntsman, F Carneiro, FR Lewis, PM MacLeod, A Hayashi, ...","New England Journal of Medicine 344 (25), 1904-1909",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8378664001664056104,454,2001
EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer,"L Hughes-Davies, D Huntsman, M Ruas, F Fuks, J Bye, SF Chin, J Milner, ...","Cell 115 (5), 523-535",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1692358244443845085,446,2003
Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria,"AR Brooks-Wilson, P Kaurah, G Suriano, S Leach, J Senz, N Grehan, ...","Journal of medical genetics 41 (7), 508-517",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1332337766518345004,413,2004
"Chromatin modifier enzymes, the histone code and cancer","H Santos-Rosa, C Caldas","European journal of cancer 41 (16), 2381-2402",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5550620654347543047,408,2005
Identification of germ-line E-cadherin mutations in gastric cancer families of European origin,"SA Gayther, KL Gorringe, SJ Ramus, D Huntsman, F Roviello, N Grehan, ...","Cancer research 58 (18), 4086-4089",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12057932656615529760,406,1998
Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution,"P Eirew, A Steif, J Khattra, G Ha, D Yap, H Farahani, K Gelmon, S Chia, ...","Nature 518 (7539), 422",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2011135715722807331,398,2015
"Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32,825 patients","R Stuart-Harris, C Caldas, SE Pinder, P Pharoah","The Breast 17 (4), 323-334",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3221564781719612792,390,2008
Somatic mutations in the ,"PDP Pharoah, NE Day, C Caldas","British journal of cancer 80 (12), 1968",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=652255637795041273,387,1999
Toward understanding and exploiting tumor heterogeneity,"AA Alizadeh, V Aranda, A Bardelli, C Blanpain, C Bock, C Borowski, ...","Nature medicine 21 (8), 846",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12748584029464635920,375,2015
Allelotype of pancreatic adenocarcinoma using xenograft enrichment,"SA Hahn, AB Seymour, ATMS Hoque, M Schutte, LT da Costa, ...","Cancer research 55 (20), 4670-4675",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=334633170770751940,359,1995
Progesterone receptor modulates ERα action in breast cancer,"H Mohammed, IA Russell, R Stark, OM Rueda, TE Hickey, GA Tarulli, ...","Nature 523 (7560), 313",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13402520934124294771,351,2015
The shaping and functional consequences of the microRNA landscape in breast cancer,"H Dvinge, A Git, S Gräf, M Salmon-Divon, C Curtis, A Sottoriva, Y Zhao, ...","Nature 497 (7449), 378",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15854195988022071423,351,2013
Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patients,"HR Ali, E Provenzano, SJ Dawson, FM Blows, B Liu, M Shah, HM Earl, ...","Annals of oncology 25 (8), 1536-1543",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10625334092187737559,329,2014
E-cadherin gene (,"JC Machado, C Oliveira, R Carvalho, P Soares, G Berx, C Caldas, ...","Oncogene 20 (12), 1525",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=245281487612772506,316,2001
High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer,"SF Chin, AE Teschendorff, JC Marioni, Y Wang, NL Barbosa-Morais, ...","Genome biology 8 (10), R215",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2535274609892676663,310,2007
The implications of clonal genome evolution for cancer medicine,"S Aparicio, C Caldas","New England journal of medicine 368 (9), 842-851",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15560594785092228226,303,2013
Hereditary diffuse gastric cancer syndrome: CDH1 mutations and beyond,"S Hansford, P Kaurah, H Li-Chang, M Woo, J Senz, H Pinheiro, ...","JAMA oncology 1 (1), 23-32",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=523203431492727920,292,2015
Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer,"KB Meyer, AT Maia, M O'Reilly, AE Teschendorff, SF Chin, C Caldas, ...","PLoS biology 6 (5), e108",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10996002691294126831,286,2008
Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers,"RS van der Post, IP Vogelaar, F Carneiro, P Guilford, D Huntsman, ...","Journal of medical genetics 52 (6), 361-374",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7029111412465711823,282,2015
Sizing up miRNAs as cancer genes,"C Caldas, JD Brenton","Nature medicine 11 (7), 712",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=37670460378169449,276,2005
Quantitative image analysis of cellular heterogeneity in breast tumors complements genomic profiling,"Y Yuan, H Failmezger, OM Rueda, HR Ali, S Gräf, SF Chin, RF Schwarz, ...","Science translational medicine 4 (157), 157ra143-157ra143",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9274617048391060962,265,2012
Model of the early development of diffuse gastric cancer in E‐cadherin mutation carriers and its implications for patient screening,"F Carneiro, DG Huntsman, TC Smyrk, DA Owen, R Seruca, P Pharoah, ...",The Journal of Pathology: A Journal of the Pathological Society of Great …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11389260982988992579,264,2004
Prognostic and predictive value of PDL1 expression in breast cancer,"R Sabatier, P Finetti, E Mamessier, J Adelaide, M Chaffanet, HR Ali, ...","Oncotarget 6 (7), 5449",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=406431363173261191,261,2015
Cancer genetics of epigenetic genes,"A Miremadi, MZ Oestergaard, PDP Pharoah, C Caldas","Human molecular genetics 16 (R1), R28-R49",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7111608304234726257,261,2007
Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer,"M Murtaza, SJ Dawson, K Pogrebniak, OM Rueda, E Provenzano, J Grant, ...","Nature communications 6, 8760",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3149808515631303050,260,2015
Alpha‐6 integrin is necessary for the tumourigenicity of a stem cell‐like subpopulation within the MCF7 breast cancer cell line,"M Cariati, A Naderi, JP Brown, MJ Smalley, SE Pinder, C Caldas, ...","International Journal of Cancer 122 (2), 298-304",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18159901882966084219,260,2008
Differential expression of selected histone modifier genes in human solid cancers,"H Özdağ, AE Teschendorff, AA Ahmed, SJ Hyland, C Blenkiron, L Bobrow, ...","BMC genomics 7 (1), 90",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12573714822437924226,259,2006
Bcl-2 is a prognostic marker in breast cancer independently of the Nottingham Prognostic Index,"GM Callagy, PD Pharoah, SE Pinder, FD Hsu, TO Nielsen, J Ragaz, ...","Clinical cancer research 12 (8), 2468-2475",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4888523811015952256,255,2006
A gene-expression signature to predict survival in breast cancer across independent data sets,"A Naderi, AE Teschendorff, NL Barbosa-Morais, SE Pinder, AR Green, ...","Oncogene 26 (10), 1507","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2066336748631150056,3927284954179291582",252,2007
Combined single-cell functional and gene expression analysis resolves heterogeneity within stem cell populations,"NK Wilson, DG Kent, F Buettner, M Shehata, IC Macaulay, ...","Cell stem cell 16 (6), 712-724",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7616713614936653089,251,2015
BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received,"SJ Dawson, N Makretsov, FM Blows, KE Driver, E Provenzano, ...","British journal of cancer 103 (5), 668-675",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11481570802019309686,243,2010
Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor,"H Mohammed, C D’Santos, AA Serandour, HR Ali, GD Brown, A Atkins, ...","Cell reports 3 (2), 342-349",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2359736327618486674,237,2013
Allelotype of pancreatic adenocarcinoma,"AB Seymour, RH Hruban, M Redston, C Caldas, SM Powell, KW Kinzler, ...","Cancer research 54 (10), 2761-2764",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4067256199692975802,236,1994
Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis,"JMJ Weaver, CS Ross-Innes, N Shannon, AG Lynch, T Forshew, ...","Nature genetics 46 (8), 837",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10850118794436257288,228,2014
Phenotypic and functional characterisation of the luminal cell hierarchy of the mammary gland,"M Shehata, A Teschendorff, G Sharp, N Novcic, IA Russell, S Avril, ...","Breast Cancer Research 14 (5), R134",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2901027963528744112,228,2012
Interrogating open issues in cancer precision medicine with patient-derived xenografts,"AT Byrne, DG Alférez, F Amant, D Annibali, J Arribas, AV Biankin, A Bruna, ...","Nature Reviews Cancer 17 (4), 254",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7621970291738849260,226,2017
Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes,"JMC Tubio, Y Li, YS Ju, I Martincorena, SL Cooke, M Tojo, G Gundem, ...","Science 345 (6196), 1251343",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=227750673717351025,226,2014
Mechanisms and sequelae of E‐cadherin silencing in hereditary diffuse gastric cancer,"M Barber, A Murrell, Y Ito, AT Maia, S Hyland, C Oliveira, V Save, ...",The Journal of Pathology: A Journal of the Pathological Society of Great …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4273478731756017824,219,2008
A new genome‐driven integrated classification of breast cancer and its implications,"SJ Dawson, OM Rueda, S Aparicio, C Caldas","The EMBO journal 32 (5), 617-628",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12663717054755503687,218,2013
Triple negative breast cancers: clinical and prognostic implications,"SJ Dawson, E Provenzano, C Caldas","European journal of cancer 45, 27-40",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18208937101810074965,211,2009
Germline              ,"C Oliveira, J Senz, P Kaurah, H Pinheiro, R Sanges, A Haegert, G Corso, ...","Human molecular genetics 18 (9), 1545-1555",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9076064844997840182,209,2009
Molecular classification of breast carcinomas using tissue microarrays,"G Callagy, E Cattaneo, Y Daigo, L Happerfield, LG Bobrow, PDP Pharoah, ...","Diagnostic Molecular Pathology 12 (1), 27-34",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3945481363295879639,207,2003
PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer,"GC Wishart, EM Azzato, DC Greenberg, J Rashbass, O Kearins, ...","Breast Cancer Research 12 (1), R1",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7311217134256796654,192,2010
A biobank of breast cancer explants with preserved intra-tumor heterogeneity to screen anticancer compounds,"A Bruna, OM Rueda, W Greenwood, AS Batra, M Callari, RN Batra, ...","Cell 167 (1), 260-274. e22",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15063069969109823242,190,2016
Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancer,"GM Callagy, MJ Webber, PDP Pharoah, C Caldas","BMC cancer 8 (1), 153",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2488169711300689805,182,2008
The extracellular matrix protein TGFBI induces microtubule stabilization and sensitizes ovarian cancers to paclitaxel,"AA Ahmed, AD Mills, AEK Ibrahim, J Temple, C Blenkiron, M Vias, ...","Cancer cell 12 (6), 514-527",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12169371765904590085,179,2007
K-ras mutation and pancreatic adenocarcinoma,"C Caldas, SE Kern","International journal of pancreatology 18 (1), 1-6",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5947182247664822988,177,1995
Molecular genetic profiles of colitis-associated neoplasms,"SE Kern, M Redston, AB Seymour, C Caldas, SM Powell, S Kornacki, ...","Gastroenterology 107 (2), 420-428",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12557965246360536474,177,1994
Impact of genomics on drug discovery and clinical medicine,"G Emilien, M Ponchon, C Caldas, O Isacson, JM Maloteaux","Qjm 93 (7), 391-423",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16229148288626169233,176,2000
Integrative analysis of genome-wide loss of heterozygosity and monoallelic expression at nucleotide resolution reveals disrupted pathways in triple-negative breast cancer,"G Ha, A Roth, D Lai, A Bashashati, J Ding, R Goya, R Giuliany, J Rosner, ...","Genome research 22 (10), 1995-2007",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=430471768112300647,174,2012
Identification of ,"G Suriano, C Oliveira, P Ferreira, JC Machado, MC Bordin, O De Wever, ...","Human molecular genetics 12 (5), 575-582",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15814869308541062436,174,2003
Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium,"A Broeks, MK Schmidt, ME Sherman, FJ Couch, JL Hopper, GS Dite, ...","Human molecular genetics 20 (16), 3289-3303",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9542835041024159313,169,2011
Identification and validation of prognostic markers in breast cancer with the complementary use of array‐CGH and tissue microarrays,"G Callagy, P Pharoah, SF Chin, T Sangan, Y Daigo, L Jackson, C Caldas",The Journal of Pathology: A Journal of the Pathological Society of Great …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=456613677523304059,169,2005
Maintaining tumor heterogeneity in patient-derived tumor xenografts,"JW Cassidy, C Caldas, A Bruna","Cancer research 75 (15), 2963-2968",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18403897656148250699,168,2015
Screening E‐cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred,"C Oliveira, MC Bordin, N Grehan, D Huntsman, G Suriano, JC Machado, ...","Human mutation 19 (5), 510-517",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16460622258870214263,162,2002
A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus,"DM Levine, WE Ek, R Zhang, X Liu, L Onstad, C Sather, P Lao-Sirieix, ...","Nature genetics 45 (12), 1487",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11767699368081109343,158,2013
p300 regulates p53-dependent apoptosis after DNA damage in colorectal cancer cells by modulation of PUMA/p21 levels,"NG Iyer, SF Chin, H Ozdag, Y Daigo, DE Hu, M Cariati, K Brindle, ...","Proceedings of the National Academy of Sciences 101 (19), 7386-7391",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15394355844865319378,158,2004
Oslo Breast Cancer Consortium (OSBREAC)(2012). The landscape of cancer genes and mutational processes in breast cancer,"PJ Stephens, PS Tarpey, H Davies, P Van Loo, C Greenman, DC Wedge, ...","Nature 486 (7403), 400-404",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11543213380536064963,157,0
"PD-L1 protein expression in breast cancer is rare, enriched in basal-like tumours and associated with infiltrating lymphocytes","HR Ali, SE Glont, FM Blows, E Provenzano, SJ Dawson, B Liu, L Hiller, ...","Annals of Oncology 26 (7), 1488-1493",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8194359637500529962,156,2015
"A comprehensive analysis of prognostic signatures reveals the high predictive capacity of the proliferation, immune response and RNA splicing modules in breast cancer","F Reyal, MH Van Vliet, NJ Armstrong, HM Horlings, KE de Visser, M Kok, ...","Breast Cancer Research 10 (6), R93",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3060320916499025588,150,2008
Genomic architecture characterizes tumor progression paths and fate in breast cancer patients,"HG Russnes, HKM Vollan, OC Lingjærde, A Krasnitz, P Lundin, B Naume, ...","Science translational medicine 2 (38), 38ra47-38ra47",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12938713439541255987,148,2010
A 1 Mb minimal amplicon at 8p11–12 in breast cancer identifies new candidate oncogenes,"MJ Garcia, JCM Pole, SF Chin, A Teschendorff, A Naderi, H Ozdag, ...","Oncogene 24 (33), 5235",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7101627490207501433,148,2005
Prophylactic total gastrectomy for familial gastric cancer,"FR Lewis, JD Mellinger, A Hayashi, D Lorelli, KG Monaghan, F Carneiro, ...","Surgery 130 (4), 612-619",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=806471283063769131,148,2001
Common occurrence of APC and K-ras gene mutations in the spectrum of colitis-associated neoplasias,"MS Redston, N Papadopoulos, C Caldas, KW Kinzler, SE Kern","Gastroenterology 108 (2), 383-392",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9755857792038645650,148,1995
TP53 mutation spectrum in breast cancer is subtype specific and has distinct prognostic relevance,"L Silwal-Pandit, HKM Vollan, SF Chin, OM Rueda, S McKinney, T Osako, ...","Clinical Cancer Research 20 (13), 3569-3580",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9859096819741294913,139,2014
Predictive markers of anthracycline benefit: a prospectively planned analysis of the UK National Epirubicin Adjuvant Trial (NEAT/BR9601),"JMS Bartlett, AF Munro, JA Dunn, C McConkey, S Jordan, CJ Twelves, ...","The lancet oncology 11 (3), 266-274",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8628907002871276613,133,2010
Copynumber: efficient algorithms for single-and multi-track copy number segmentation,"G Nilsen, K Liestøl, P Van Loo, HKM Vollan, MB Eide, OM Rueda, ...","BMC genomics 13 (1), 591",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12844138130906790051,131,2012
PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2,"GC Wishart, CD Bajdik, E Dicks, E Provenzano, MK Schmidt, M Sherman, ...","British journal of cancer 107 (5), 800-807",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9014733654321646473,129,2012
DriverNet: uncovering the impact of somatic driver mutations on transcriptional networks in cancer,"A Bashashati, G Haffari, J Ding, G Ha, K Lui, J Rosner, DG Huntsman, ...","Genome biology 13 (12), R124",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9349928380989299635,128,2012
Micro-RNAs and breast cancer,"J Le Quesne, C Caldas","Molecular oncology 4 (3), 230-241",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16970200828363857882,128,2010
EEN encodes for a member of a new family of proteins containing an Src homology 3 domain and is the third gene located on chromosome 19p13 that fuses to MLL in human leukemia,"CW So, C Caldas, MM Liu, SJ Chen, QH Huang, LJ Gu, MH Sham, ...","Proceedings of the National Academy of Sciences 94 (6), 2563-2568",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10293909991518765204,128,1997
Clinical implications of E-cadherin associated hereditary diffuse gastric cancer,"RC Fitzgerald, C Caldas","Gut 53 (6), 775-778",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13049541278720589015,124,2004
"Genome-driven integrated classification of breast cancer validated in over 7,500 samples","HR Ali, OM Rueda, SF Chin, C Curtis, MJ Dunning, SAJR Aparicio, ...","Genome biology 15 (8), 431",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2807204005053172501,123,2014
Australian Pancreatic Cancer Genome I,"LB Alexandrov, S Nik-Zainal, DC Wedge, SA Aparicio, S Behjati, ...","Consortium IBC, Consortium IM-S, PedBrain I, Zucman-Rossi J, Futreal PA …",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11383608783273058926,123,2013
Circulating tumor DNA to monitor metastatic breast cancer.,"M Cristofanilli, P Fortina","Massachusetts Medical Society. 369 (1), 93",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16249065612645318312,122,2013
A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer,"P Polak, J Kim, LZ Braunstein, R Karlic, NJ Haradhavala, G Tiao, ...","Nature genetics 49 (10), 1476",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2054125993828733775,121,2017
", the second human homolog of the ","DG Huntsman, SF Chin, M Muleris, SJ Batley, VP Collins, LM Wiedemann, ...","Oncogene 18 (56), 7975",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12162773317399476160,121,1999
Evidence for a role of FGF‐2 and FGF receptors in the proliferation of non‐small cell lung cancer cells,"W Berger, U Setinek, T Mohr, I Kindas‐Mügge, M Vetterlein, G Dekan, ...","International journal of cancer 83 (3), 415-423",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14688908085349275386,121,1999
Degenerate oligonucleotide primed-polymerase chain reaction-based array comparative genomic hybridization for extensive amplicon profiling of breast cancers: a new approach for …,"Y Daigo, SF Chin, KL Gorringe, LG Bobrow, BAJ Ponder, PDP Pharoah, ...","The American journal of pathology 158 (5), 1623-1631",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6779549905913085457,120,2001
Elucidating the altered transcriptional programs in breast cancer using independent component analysis,"AE Teschendorff, M Journée, PA Absil, R Sepulchre, C Caldas","PLoS computational biology 3 (8), e161",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9839605081511764812,119,2007
Pharmacogenomic identification of novel determinants of response to chemotherapy in colon cancer,"J Boyer, WL Allen, EG McLean, PM Wilson, A McCulla, S Moore, ...","Cancer research 66 (5), 2765-2777",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15888839729107081404,119,2006
The pitfalls of platform comparison: DNA copy number array technologies assessed,"C Curtis, AG Lynch, MJ Dunning, I Spiteri, JC Marioni, J Hadfield, SF Chin, ...","BMC genomics 10 (1), 588",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4847816381096072278,118,2009
Dysregulated expression of Fau and MELK is associated with poor prognosis in breast cancer,"MR Pickard, AR Green, IO Ellis, C Caldas, VL Hedge, ...","Breast cancer research 11 (4), R60",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12145427381258015302,117,2009
Cytokine gene polymorphisms and the risk of adenocarcinoma of the stomach in the European prospective investigation into cancer and nutrition (EPIC-EURGAST),"JBA Crusius, F Canzian, G Capella, AS Pena, G Pera, N Sala, A Agudo, ...","Annals of Oncology 19 (11), 1894-1902",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4560837306781139597,117,2008
Using array-comparative genomic hybridization to define molecular portraits of primary breast cancers,"SF Chin, Y Wang, NP Thorne, AE Teschendorff, SE Pinder, M Vias, ...","Oncogene 26 (13), 1959",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17043150273752684129,117,2007
"A 4-gene signature predicts survival of patients with resected adenocarcinoma of the esophagus, junction, and gastric cardia","CJ Peters, JRE Rees, RH Hardwick, JS Hardwick, SL Vowler, CAJ Ong, ...","Gastroenterology 139 (6), 1995-2004. e15",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10368122242052503918,116,2010
Characterisation of microRNA expression in post-natal mouse mammary gland development,"S Avril-Sassen, LD Goldstein, J Stingl, C Blenkiron, J Le Quesne, I Spiteri, ...","BMC genomics 10 (1), 548",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1288908254873277989,115,2009
CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1/2 deficient tumours,"H Xu, M Di Antonio, S McKinney, V Mathew, B Ho, NJ O’Neil, ...","Nature communications 8, 14432",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3900880632669155802,113,2017
Preoperative GNAS and KRAS testing in the diagnosis of pancreatic mucinous cysts,"AD Singhi, MN Nikiforova, KE Fasanella, KM McGrath, RK Pai, NP Ohori, ...","Clinical Cancer Research 20 (16), 4381-4389",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9760589648814321064,111,2014
Molecular cytogenetic analysis of breast cancer cell lines,"JM Davidson, KL Gorringe, SF Chin, B Orsetti, C Besret, C Courtay-Cahen, ...","British journal of cancer 83 (10), 1309",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12743653279422223566,111,2000
Patterns of immune infiltration in breast cancer and their clinical implications: a gene-expression-based retrospective study,"HR Ali, L Chlon, PDP Pharoah, F Markowetz, C Caldas","PLoS medicine 13 (12), e1002194",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=165049377783248259,110,2016
Common germline genetic variation in antioxidant defense genes and survival after diagnosis of breast cancer,"M Udler, AT Maia, A Cebrian, C Brown, D Greenberg, M Shah, C Caldas, ...","Journal of Clinical Oncology 25 (21), 3015-3023",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17438257442480200549,110,2007
Somatic mutations reveal asymmetric cellular dynamics in the early human embryo,"YS Ju, I Martincorena, M Gerstung, M Petljak, LB Alexandrov, R Rahbari, ...","Nature 543 (7647), 714",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10000875687621076821,109,2017
JARID1B is a luminal lineage-driving oncogene in breast cancer,"S Yamamoto, Z Wu, HG Russnes, S Takagi, G Peluffo, C Vaske, X Zhao, ...","Cancer cell 25 (6), 762-777",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5282297749492019575,109,2014
Histopathological and molecular analysis of gastrectomy specimens from hereditary diffuse gastric cancer patients has implications for endoscopic surveillance of individuals at …,"ME Barber, V Save, F Carneiro, S Dwerryhouse, P Lao‐Sirieix, ...",The Journal of Pathology: A Journal of the Pathological Society of Great …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1283516905974386003,105,2008
Aberrant splicing of the ,"SA Gayther, P Barski, SJ Batley, L Li, KAF de Foy, SN Cohen, BAJ Ponder, ...","Oncogene 15 (17), 2119",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14332314463208273760,104,1997
Regulation of p53 tetramerization and nuclear export by ARC,"RSY Foo, YJ Nam, MJ Ostreicher, MD Metzl, RS Whelan, CF Peng, ...","Proceedings of the National Academy of Sciences 104 (52), 20826-20831",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4271357889326651735,103,2007
A consensus prognostic gene expression classifier for ER positive breast cancer,"AE Teschendorff, A Naderi, NL Barbosa-Morais, SE Pinder, IO Ellis, ...","Genome biology 7 (10), R101",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4634945098682185850,102,2006
"Effects of the addition of gemcitabine, and paclitaxel-first sequencing, in neoadjuvant sequential epirubicin, cyclophosphamide, and paclitaxel for women with high-risk early …","HM Earl, AL Vallier, L Hiller, N Fenwick, J Young, M Iddawela, J Abraham, ...","The lancet oncology 15 (2), 201-212",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3703070866216478717,101,2014
Master regulators of FGFR2 signalling and breast cancer risk,"MNC Fletcher, MAA Castro, X Wang, I De Santiago, M O’Reilly, SF Chin, ...","Nature communications 4, 2464",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11089828035361098693,100,2013
A simple and reliable pretreatment protocol facilitates fluorescent in situ hybridisation on tissue microarrays of paraffin wax embedded tumour samples,"SF Chin, Y Daigo, HE Huang, NG Iyer, G Callagy, T Kranjac, M Gonzalez, ...","Molecular Pathology 56 (5), 275",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14016626807078468971,98,2003
CYP2D6 gene variants: association with breast cancer specific survival in a cohort of breast cancer patients from the United Kingdom treated with adjuvant tamoxifen,"JE Abraham, MJ Maranian, KE Driver, R Platte, B Kalmyrzaev, C Baynes, ...","Breast Cancer Research 12 (4), R64",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12662831488232814051,97,2010
Human and mouse oligonucleotide-based array CGH,"P Van Den Ijssel, M Tijssen, SF Chin, P Eijk, B Carvalho, E Hopmans, ...","Nucleic Acids Research 33 (22), e192-e192",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15698791330934746089,96,2005
Microarray segmentation methods significantly influence data precision,"AA Ahmed, M Vias, NG Iyer, C Caldas, JD Brenton","Nucleic Acids Research 32 (5), e50-e50",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15860478603367391657,96,2004
Saliva samples are a viable alternative to blood samples as a source of DNA for high throughput genotyping,"JE Abraham, MJ Maranian, I Spiteri, R Russell, S Ingle, C Luccarini, ...","BMC medical genomics 5 (1), 19",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17925921918513383216,95,2012
"Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance","HR Ali, SJ Dawson, FM Blows, E Provenzano, PD Pharoah, C Caldas","Breast Cancer Research 13 (6), R118",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11357978468698704816,95,2011
Improved prognostic classification of breast cancer defined by antagonistic activation patterns of immune response pathway modules,"AE Teschendorff, S Gomez, A Arenas, D El-Ashry, M Schmidt, ...","BMC cancer 10 (1), 604",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1611645132465045006,93,2010
"Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer","M Michaut, SF Chin, I Majewski, TM Severson, T Bismeijer, L De Koning, ...","Scientific reports 6, 18517",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2860808471051584184,92,2016
ZNF703 is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epithelium,"DG Holland, A Burleigh, A Git, MA Goldgraben, PA Perez‐Mancera, ...","EMBO molecular medicine 3 (3), 167-180",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1810684306135452312,92,2011
Dihydroorotate dehydrogenase inhibitor A771726 (leflunomide) induces apoptosis and diminishes proliferation of multiple myeloma cells,"P Baumann, S Mandl-Weber, A Völkl, C Adam, I Bumeder, F Oduncu, ...","Molecular cancer therapeutics 8 (2), 366-375","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1953375412920595789,9729728147402288705",92,2009
A robust classifier of high predictive value to identify good prognosis patients in ER-negative breast cancer,"AE Teschendorff, C Caldas","Breast Cancer Research 10 (4), R73",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2559818714892328516,91,2008
International Gastric Cancer Linkage Consortium. Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer …,"P Pharoah, P Guilford, C Caldas","GASTROENTEROLOGY 121 (6), 1348-1353",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8022924764057129799,91,2001
Systematic analysis of challenge-driven improvements in molecular prognostic models for breast cancer,"AA Margolin, E Bilal, E Huang, TC Norman, L Ottestad, BH Mecham, ...","Science translational medicine 5 (181), 181re1-181re1",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10945624328973125000,90,2013
"High-resolution analysis of chromosome rearrangements on 8p in breast, colon and pancreatic cancer reveals a complex pattern of loss, gain and translocation","JCM Pole, C Courtay-Cahen, MJ Garcia, KA Blood, SL Cooke, AE Alsop, ...","Oncogene 25 (41), 5693",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1991195700699446867,89,2006
Evidence that breast cancer risk at the 2q35 locus is mediated through ,"M Ghoussaini, SL Edwards, K Michailidou, S Nord, R Cowper-Sal, ...","Nature communications 5, 4999",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1719057635446016259,87,2014
 is a triple-negative breast cancer gene with critical functions in stem and progenitor cells,"WT Khaled, SC Lee, J Stingl, X Chen, HR Ali, OM Rueda, F Hadi, J Wang, ...","Nature communications 6, 5987",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10749021337416305310,86,2015
A population-based validation of the prognostic model PREDICT for early breast cancer,"GC Wishart, CD Bajdik, EM Azzato, E Dicks, DC Greenberg, J Rashbass, ...","European Journal of Surgical Oncology (EJSO) 37 (5), 411-417",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5013981669014903180,83,2011
A variational Bayesian mixture modelling framework for cluster analysis of gene-expression data,"AE Teschendorff, Y Wang, NL Barbosa-Morais, JD Brenton, C Caldas","Bioinformatics 21 (13), 3025-3033",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18390970329087612241,83,2005
DNA repair polymorphisms and the risk of stomach adenocarcinoma and severe chronic gastritis in the EPIC-EURGAST study,"G Capellá, G Pera, N Sala, A Agudo, F Rico, G Del Giudicce, M Plebani, ...","International journal of epidemiology 37 (6), 1316-1325",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13407843877526181749,81,2008
BEX2 is overexpressed in a subset of primary breast cancers and mediates nerve growth factor/nuclear factor-κB inhibition of apoptosis in breast cancer cell lines,"A Naderi, AE Teschendorff, J Beigel, M Cariati, IO Ellis, JD Brenton, ...","Cancer research 67 (14), 6725-6736",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14884849656977393586,81,2007
G-quadruplex DNA as a molecular target for induced synthetic lethality in cancer cells,"KIE McLuckie, M Di Antonio, H Zecchini, J Xian, C Caldas, ...","Journal of the American Chemical Society 135 (26), 9640-9643",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12845460078169344937,80,2013
A Children's Oncology Group and TARGET initiative exploring the genetic landscape of Wilms tumor,"S Gadd, V Huff, AL Walz, AHAG Ooms, AE Armstrong, DS Gerhard, ...","Nature genetics 49 (10), 1487",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1227376534547016285,78,2017
"Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis …","HM Earl, L Hiller, JA Dunn, C Blenkinsop, L Grybowicz, AL Vallier, ...","The lancet oncology 16 (6), 656-666",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11555968229777439346,78,2015
A recurrent chromosome breakpoint in breast cancer at the NRG1/neuregulin 1/heregulin gene,"HE Huang, SF Chin, C Ginestier, VJ Bardou, J Adélaïde, NG Iyer, ...","Cancer research 64 (19), 6840-6844",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7850255547544472124,78,2004
Promoter of lncRNA gene PVT1 is a tumor-suppressor DNA boundary element,"SW Cho, J Xu, R Sun, MR Mumbach, AC Carter, YG Chen, KE Yost, J Kim, ...","Cell 173 (6), 1398-1412. e22",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15014022260645446027,77,2018
Familial gastric cancer–aetiology and pathogenesis,"M Barber, RC Fitzgerald, C Caldas","Best Practice & Research Clinical Gastroenterology 20 (4), 721-734",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18035264438602322643,77,2006
Cancer: The molecular outlook,"C Caldas, SAJ Aparicio","Nature 415 (6871), 484",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9630132186573762925,77,2002
The ,"YL Chua, Y Ito, JCM Pole, S Newman, SF Chin, RC Stein, IO Ellis, ...","Oncogene 28 (46), 4041",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16413530751119397796,75,2009
Molecular classification of solid tumours: towards pathway-driven therapeutics,"C Swanton, C Caldas","British journal of cancer 100 (10), 1517",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9785433260613521608,75,2009
Integrative analysis of array-comparative genomic hybridisation and matched gene expression profiling data reveals novel genes with prognostic significance in oesophageal …,"XY Goh, JRE Rees, AL Paterson, SF Chin, JC Marioni, V Save, ...","Gut 60 (10), 1317-1326",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5346247725614375766,74,2011
 gene amplification in breast cancer: a common phenomenon?,"LA Brown, J Hoog, SF Chin, Y Tao, AA Zayed, K Chin, AE Teschendorff, ...","Nature genetics 40 (7), 806",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15489365504128377505,74,2008
A Ki67/BCL2 index based on immunohistochemistry is highly prognostic in ER‐positive breast cancer,"HR Ali, SJ Dawson, FM Blows, E Provenzano, S Leung, T Nielsen, ...","The Journal of pathology 226 (1), 97-107",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15369110440957047974,73,2012
PACK: Profile Analysis using Clustering and Kurtosis to find molecular classifiers in cancer,"AE Teschendorff, A Naderi, NL Barbosa-Morais, C Caldas","Bioinformatics 22 (18), 2269-2275",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13767768011039662044,72,2006
Molecular characteristics of screen-detected ,"SJ Dawson, SW Duffy, FM Blows, KE Driver, E Provenzano, J LeQuesne, ...","British journal of cancer 101 (8), 1338",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7474015203591641306,71,2009
Cell-free circulating tumour DNA as a liquid biopsy in breast cancer,"L De Mattos-Arruda, C Caldas","Molecular oncology 10 (3), 464-474",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8058378643855692852,70,2016
Improving breast cancer survival analysis through competition-based multidimensional modeling,"E Bilal, J Dutkowski, J Guinney, IS Jang, BA Logsdon, G Pandey, ...","PLoS computational biology 9 (5), e1003047",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17835640892623135826,70,2013
TGFβ induces the formation of tumour-initiating cells in claudin,"A Bruna, W Greenwood, J Le Quesne, A Teschendorff, ...","Nature communications 3, 1055",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5691204253962874652,69,2012
Biological and prognostic associations of ,"JL Quesne, J Jones, J Warren, SJ Dawson, HR Ali, H Bardwell, F Blows, ...","The Journal of pathology 227 (3), 306-314",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14522896117446678959,69,2012
Impaired transforming growth factor β signalling in Barrett’s carcinogenesis due to frequent SMAD4 inactivation,"BA Onwuegbusi, A Aitchison, SF Chin, T Kranjac, I Mills, Y Huang, ...","Gut 55 (6), 764-774",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15858614345756033115,68,2006
Mutation analysis of CBP and PCAF reveals rare inactivating mutations in cancer cell lines but not in primary tumours,"H Özdağ, SJ Batley, A Försti, NG Iyer, Y Daigo, J Boutell, MJ Arends, ...","British journal of cancer 87 (10), 1162",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12270640173663574283,67,2002
Facilitating a culture of responsible and effective sharing of cancer genome data,"LL Siu, M Lawler, D Haussler, BM Knoppers, J Lewin, DJ Vis, RG Liao, ...","Nature medicine 22 (5), 464",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15199583458485116270,65,2016
Genetic screening for hereditary diffuse gastric cancer,"COR Seruca, C Caldas","Expert review of molecular diagnostics 3 (2), 201-215",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10532190604880985457,65,2003
Replication of genetic polymorphisms reported to be associated with taxane-related sensory neuropathy in patients with early breast cancer treated with Paclitaxel,"JE Abraham, Q Guo, L Dorling, J Tyrer, S Ingle, R Hardy, AL Vallier, ...","Clinical Cancer Research 20 (9), 2466-2475",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1620043060325241812,64,2014
PERSEPHONE: 6 versus 12 months (m) of adjuvant trastuzumab in patients (pts) with HER2 positive (+) early breast cancer (EBC): randomised phase 3 non-inferiority trial with …,"HM Earl, L Hiller, AL Vallier, S Loi, D Howe, HB Higgins, K McAdam, ...","Journal of Clinical Oncology 36 (15_suppl), 506-506",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5730155664559980507,62,2018
Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis,"P Gharahkhani, RC Fitzgerald, TL Vaughan, C Palles, I Gockel, ...","The Lancet Oncology 17 (10), 1363-1373",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5296160115452632736,62,2016
Genetic predisposition to gastro-oesophageal cancer,"P Lao-Sirieix, C Caldas, RC Fitzgerald","Current opinion in genetics & development 20 (3), 210-217",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2465733038671272195,62,2010
Fine scale mapping of the breast cancer 16q12 locus,"MS Udler, S Ahmed, CS Healey, K Meyer, J Struewing, M Maranian, ...","Human molecular genetics 19 (12), 2507-2515",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13019805684637455049,62,2010
CDH1 c‐160a promotor polymorphism is not associated with risk of stomach cancer,"PDP Pharoah, C Oliveira, JC Machado, G Keller, H Vogelsang, H Laux, ...","International journal of cancer 101 (2), 196-197",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9997528816174501224,62,2002
Exon scrambling of MLL transcripts occur commonly and mimic partial genomic duplication of the gene,"C Caldas, CW So, A MacGregor, AM Ford, B McDonald, LC Chan, ...","Gene 208 (2), 167-176",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11870618208784112771,62,1998
Frequent somatic deletion of the 13q12. 3 locus encompassing BRCA2 in chronic lymphocytic leukemia,"JA Garcia-Marco, C Caldas, CM Price, LM Wiedemann, A Ashworth, ...","Blood 88 (5), 1568-1575",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=313924396645471413,62,1996
The malignant phenotype in breast cancer is driven by eIF4A1-mediated changes in the translational landscape,"A Modelska, E Turro, R Russell, J Beaton, T Sbarrato, K Spriggs, J Miller, ...","Cell death & disease 6 (1), e1603",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8645815116758348773,61,2015
Aurora kinase A outperforms Ki67 as a prognostic marker in ER-positive breast cancer,"HR Ali, SJ Dawson, FM Blows, E Provenzano, PD Pharoah, C Caldas","British journal of cancer 106 (11), 1798",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8753323683252535260,61,2012
Report on the first meeting of the International Collaborative Group on Hereditary Gastric Cancer,"JG Park, HK Yang, WH Kim, C Caldas, J Yokota, PJ Guilford","Journal of the National Cancer Institute 92 (21), 1781-1782",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16706711239717370931,61,2000
Consensus on precision medicine for metastatic cancers: a report from the MAP conference,"C Swanton, JC Soria, A Bardelli, A Biankin, C Caldas, S Chandarlapaty, ...","Annals of oncology 27 (8), 1443-1448",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9716990136890529273,60,2016
Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancer,"TMA Abdel-Fatah, R Russell, N Albarakati, DJ Maloney, D Dorjsuren, ...","Molecular oncology 8 (7), 1326-1338",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15912763172029983454,60,2014
p300 is required for orderly G1/S transition in human cancer cells,"NG Iyer, J Xian, SF Chin, AJ Bannister, Y Daigo, S Aparicio, T Kouzarides, ...","Oncogene 26 (1), 21",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10612524561804167661,59,2007
Pharmacogenetics of cancer chemotherapy,"J Abraham, HM Earl, PD Pharoah, C Caldas","Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1766 (2), 168-183",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5566154585917676623,59,2006
Expression microarray reproducibility is improved by optimising purification steps in RNA amplification and labelling,"A Naderi, AA Ahmed, NL Barbosa-Morais, S Aparicio, JD Brenton, ...","BMC genomics 5 (1), 9",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6419248044533603118,58,2004
The role of FeS and (NH4) 2CO3 additives on the pressed type Fe electrode,"CA Caldas, MC Lopes, IA Carlos","Journal of power sources 74 (1), 108-112",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6399692137859937758,58,1998
Genomic imbalances and patterns of karyotypic variability in mantle-cell lymphoma cell lines,"J Camps, I Salaverria, MJ Garcia, E Prat, S Beà, JC Pole, L Hernández, ...","Leukemia research 30 (8), 923-934",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12370623132753229008,57,2006
Patient-derived xenograft models: an emerging platform for translational cancer research. Cancer Discov. 2014; 4: 998–1013. doi: 10.1158/2159-8290,"M Hidalgo, F Amant, AV Biankin, E Budinska, AT Byrne, C Caldas, ...",CD-14-0001.[PMC free article][PubMed][Cross Ref],https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8696933871434499280,56,0
Breast cancer molecular stratification: from intrinsic subtypes to integrative clusters,"HG Russnes, OC Lingjaerde, AL Børresen-Dale, C Caldas","The American journal of pathology 187 (10), 2152-2162",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9856030138055438684,55,2017
Array comparative genomic hybridization copy number profiling: a new tool for translational research in solid malignancies,"JL Costa, G Meijer, B Ylstra, C Caldas","Seminars in radiation oncology 18 (2), 98-104",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15249101086038829914,55,2008
Genetic heterogeneity in breast cancer: the road to personalized medicine?,"RD Baird, C Caldas","BMC medicine 11 (1), 151",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17521345305884137090,54,2013
Whole-genome DNA/RNA sequencing identifies truncating mutations in RBCK1 in a novel Mendelian disease with neuromuscular and cardiac involvement,"K Wang, C Kim, J Bradfield, Y Guo, E Toskala, FG Otieno, C Hou, ...","Genome medicine 5 (7), 67","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1734401958168094658,10516423418715044439",54,2013
Shieldin complex promotes DNA end-joining and counters homologous recombination in BRCA1-null cells,"H Dev, TWW Chiang, C Lescale, I de Krijger, AG Martin, D Pilger, ...","Nature cell biology 20 (8), 954",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1971877093657193812,53,2018
High-resolution array CGH clarifies events occurring on 8p in carcinogenesis,"SL Cooke, JCM Pole, SF Chin, IO Ellis, C Caldas, PAW Edwards","BMC cancer 8 (1), 288",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16201995842060782870,53,2008
Cancer sequencing unravels clonal evolution,C Caldas,"Nature biotechnology 30 (5), 408",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7738115682445638448,52,2012
Modelling trade-offs between livestock grazing and wader conservation in a grassland agroecosystem,"R Sabatier, L Doyen, M Tichit","Ecological Modelling 221 (9), 1292-1300",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13268047552010464999,52,2010
Evidence that both genetic instability and selection contribute to the accumulation of chromosome alterations in cancer,"KL Gorringe, SF Chin, P Pharoah, JM Staines, C Oliveira, PAW Edwards, ...","Carcinogenesis 26 (5), 923-930",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3801053776594982871,52,2005
APOBEC3B-mediated cytidine deamination is required for estrogen receptor action in breast cancer,"M Periyasamy, H Patel, CF Lai, VTM Nguyen, E Nevedomskaya, A Harrod, ...","Cell reports 13 (1), 108-121",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9316275122077391575,50,2015
Processed pseudogenes acquired somatically during cancer development,"SL Cooke, A Shlien, J Marshall, CP Pipinikas, I Martincorena, JMC Tubio, ...","Nature communications 5, 3644",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2105203873053971169,50,2014
High-resolution magic angle spinning 1H NMR spectroscopy and reverse transcription-PCR analysis of apoptosis in a rat glioma,"JL Griffin, C Blenkiron, PK Valonen, C Caldas, RA Kauppinen","Analytical chemistry 78 (5), 1546-1552",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15861949255269602229,50,2006
Cross-platform array comparative genomic hybridization meta-analysis separates hematopoietic and mesenchymal from epithelial tumors,"K Jong, E Marchiori, A Van der Vaart, SF Chin, B Carvalho, M Tijssen, ...","Oncogene 26 (10), 1499",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5161750139045769857,49,2007
Prospective cohort study assessing outcomes of patients from families fulfilling criteria for hereditary diffuse gastric cancer undergoing endoscopic surveillance,"YC Lim, M di Pietro, M O'Donovan, S Richardson, I Debiram, ...","Gastrointestinal endoscopy 80 (1), 78-87",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18024697218599763094,48,2014
Synchronous mature teratomas of the ovary and liver: a case presenting 11 years following chemotherapy for immature teratoma,"C Caldas, J Sitzmann, CL Trimble, WP McGuire III","Gynecologic oncology 47 (3), 385-390",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5320675457564629111,48,1992
Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltration,"M Smid, FG Rodríguez-González, AM Sieuwerts, R Salgado, ...","Nature communications 7, 12910",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3182732299081359400,47,2016
Prognostic significance of androgen receptor expression in invasive breast cancer: transcriptomic and protein expression analysis,"MA Aleskandarany, R Abduljabbar, I Ashankyty, A Elmouna, D Jerjees, ...","Breast cancer research and treatment 159 (2), 215-227",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8414851051948439062,47,2016
Expression of androgen receptor splice variants in clinical breast cancers,"TE Hickey, CM Irvine, H Dvinge, GA Tarulli, AR Hanson, NK Ryan, ...","Oncotarget 6 (42), 44728",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5127418555903344561,47,2015
The proteins FABP7 and OATP2 are associated with the basal phenotype and patient outcome in human breast cancer,"H Zhang, EA Rakha, GR Ball, I Spiteri, M Aleskandarany, EC Paish, ...","Breast cancer research and treatment 121 (1), 41-51",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5117925832298187173,47,2010
A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease,"RA Scott, DF Freitag, L Li, AY Chu, P Surendran, R Young, N Grarup, ...","Science translational medicine 8 (341), 341ra76-341ra76",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5064364217304405332,46,2016
Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells,"YS Ju, JMC Tubio, W Mifsud, B Fu, HR Davies, M Ramakrishna, Y Li, ...","Genome research 25 (6), 814-824",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11737882950584612669,46,2015
Structural analysis of the genome of breast cancer cell line ZR-75-30 identifies twelve expressed fusion genes,"I Schulte, EM Batty, JCM Pole, KA Blood, S Mo, SL Cooke, C Ng, ...","BMC genomics 13 (1), 719",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10416058314400526572,46,2012
Crowdsourcing the general public for large scale molecular pathology studies in cancer,"FJC dos Reis, S Lynn, HR Ali, D Eccles, A Hanby, E Provenzano, ...","EBioMedicine 2 (7), 681-689",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12041254229222053204,45,2015
Targeting BRCA1-BER deficient breast cancer by ATM or DNA-PKcs blockade either alone or in combination with cisplatin for personalized therapy,"N Albarakati, TMA Abdel-Fatah, R Doherty, R Russell, D Agarwal, ...","Molecular oncology 9 (1), 204-217",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3555797845584842088,45,2015
"RERG (Ras-like, oestrogen-regulated, growth-inhibitor) expression in breast cancer: a marker of ER-positive luminal-like subtype","HO Habashy, DG Powe, E Glaab, G Ball, I Spiteri, N Krasnogor, ...","Breast cancer research and treatment 128 (2), 315-326",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3034165999223762087,45,2011
Absence of p300 induces cellular phenotypic changes characteristic of epithelial to mesenchyme transition,"D Krubasik, NG Iyer, WR English, AA Ahmed, M Vias, C Roskelley, ...","British journal of cancer 94 (9), 1326",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14808550370444742107,45,2006
"Possible causes of chromosome instability: comparison of chromosomal abnormalities in cancer cell lines with mutations in BRCA1, BRCA2, CHK2 and BUB1","M Grigorova, JM Staines, H Ozdag, C Caldas, PAW Edwards","Cytogenetic and genome research 104 (1-4), 333-340",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8165592439854250372,45,2004
BRCA1-like signature in triple negative breast cancer: Molecular and clinical characterization reveals subgroups with therapeutic potential,"TM Severson, J Peeters, I Majewski, M Michaut, A Bosma, PC Schouten, ...","Molecular oncology 9 (8), 1528-1538",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9565874439288633849,44,2015
The breast cancer oncogene EMSY represses transcription of antimetastatic microRNA miR-31,"E Viré, C Curtis, V Davalos, A Git, S Robson, A Villanueva, A Vidal, ...","Molecular cell 53 (5), 806-818",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1745602569830156168,43,2014
Predicting anthracycline benefit: TOP2A and CEP17-not only but also,"JM Bartlett, CC McConkey, AF Munro, C Desmedt, JA Dunn, ...","J Clin Oncol 33 (15), 1680-1687","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6498785493999573085,262644808612517211",42,2015
Pathology findings and validation of gastric and esophageal cancer cases in a European cohort (EPIC/EUR-GAST),"F Carneiro, C Moutinho, G Pera, C Caldas, C Fenger, J Offerhaus, V Save, ...","Scandinavian journal of gastroenterology 42 (5), 618-627",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13582758777763847316,42,2007
Molecular profiling of breast cancer: portraits but not physiognomy,"JD Brenton, SAJR Aparicio, C Caldas","Breast Cancer Research 3 (2), 77",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15289090290568137199,42,2001
"SPAG5 as a prognostic biomarker and chemotherapy sensitivity predictor in breast cancer: a retrospective, integrated genomic, transcriptomic, and protein analysis","TMA Abdel-Fatah, D Agarwal, DX Liu, R Russell, OM Rueda, K Liu, B Xu, ...","The Lancet Oncology 17 (7), 1004-1018",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1393525974669772166,41,2016
Cracking the epitranscriptome,S Schwartz,"RNA 22 (2), 169-174",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=698479753210165353,41,2016
Comparison of methods for handling missing data on immunohistochemical markers in survival analysis of breast cancer,"AMG Ali, SJ Dawson, FM Blows, E Provenzano, IO Ellis, L Baglietto, ...","British journal of cancer 104 (4), 693",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18008161997860239937,41,2011
RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer,"C Cruz, M Castroviejo-Bermejo, S Gutiérrez-Enríquez, A Llop-Guevara, ...","Annals of Oncology 29 (5), 1203-1210",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14751890116675726643,40,2018
Cytoplasmic reactive oxygen species and SOD1 regulate bone mass during mechanical unloading,"D Morikawa, H Nojiri, Y Saita, K Kobayashi, K Watanabe, Y Ozawa, ...","Journal of Bone and Mineral Research 28 (11), 2368-2380","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17618734501640668163,9880973623284926060,18001192663219714602,10706252965134730118,5976744957173698117",40,2013
"Common germline polymorphisms in COMT, CYP19A1, ESR1, PGR, SULT1E1 and STS and survival after a diagnosis of breast cancer","MS Udler, EM Azzato, CS Healey, S Ahmed, KA Pooley, D Greenberg, ...","International journal of cancer 125 (11), 2687-2696",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11888211985194568023,40,2009
Dihydrofolate reductase amplification and sensitization to methotrexate of methotrexate-resistant colon cancer cells,"C Morales, MJ García, M Ribas, R Miró, M Muñoz, C Caldas, MA Peinado","Molecular cancer therapeutics 8 (2), 424-432",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8690221892885970951,40,2009
Paclitaxel (Taxol) therapy in ovarian carcinoma.,C Caldas,"Seminars in oncology 20 (4 Suppl 3), 50-55",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5076824688942769237,40,1993
A co-culture genome-wide RNAi screen with mammary epithelial cells reveals transmembrane signals required for growth and differentiation,"A Burleigh, S McKinney, J Brimhall, D Yap, P Eirew, S Poon, V Ng, A Wan, ...","Breast Cancer Research 17 (1), 4",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10469907675541520025,39,2015
Identification of novel genetic markers of breast cancer survival,"Q Guo, MK Schmidt, P Kraft, S Canisius, C Chen, S Khan, J Tyrer, ...",JNCI: Journal of the National Cancer Institute 107 (5),https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9646484256366869563,39,2015
Re: CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the Breast International Group 1-98 trial and Re: CYP2D6 and UGT2B7 …,"PDP Pharoah, J Abraham, C Caldas","Journal of the National Cancer Institute 104 (16), 1263-1264",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7057690949320541171,39,2012
MYC functions are specific in biological subtypes of breast cancer and confers resistance to endocrine therapy in luminal tumours,"AR Green, MA Aleskandarany, D Agarwal, S Elsheikh, CC Nolan, ...","British journal of cancer 114 (8), 917",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5224629557045908710,38,2016
Inclusion of KI67 significantly improves performance of the PREDICT prognostication and prediction model for early breast cancer,"GC Wishart, E Rakha, A Green, I Ellis, HR Ali, E Provenzano, FM Blows, ...","BMC cancer 14 (1), 908","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3399148248788308493,1223502129967714220",38,2014
Genomic gain of 5p15 leads to over-expression of Misu (NSUN2) in breast cancer,"M Frye, I Dragoni, SF Chin, I Spiteri, A Kurowski, E Provenzano, A Green, ...","Cancer letters 289 (1), 71-80",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1927253295563775418,38,2010
Chromosome abnormalities in 10 lung cancer cell lines of the NCI-H series analyzed with spectral karyotyping,"M Grigorova, RC Lyman, C Caldas, PAW Edwards","Cancer genetics and cytogenetics 162 (1), 1-9",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3323045814594883811,38,2005
E-cadherin mutations and hereditary gastric cancer: prevention by resection?,"RC Fitzgerald, C Caldas","Digestive Diseases 20 (1), 23-31",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10658192679850649116,37,2002
Cell memory and cancer–the story of the trithorax and Polycomb group genes,"C Caldas, S Aparicio","Cancer and Metastasis Reviews 18 (2), 313-329",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10866678305051243894,37,1999
Differential gene expression in the murine gastric fundus lacking interstitial cells of Cajal,"Y Daigo, I Takayama, BAJ Ponder, C Caldas, SM Ward, KM Sanders, ...","BMC gastroenterology 3 (1), 14",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7076414160402132267,36,2003
Preclinical characterization of novel chordoma cell systems and their targeting by pharmocological inhibitors of the CDK4/6 cell-cycle pathway,"A von Witzleben, LT Goerttler, R Marienfeld, H Barth, A Lechel, K Mellert, ...","Cancer research 75 (18), 3823-3831",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17696037359434487490,35,2015
Astronomical algorithms for automated analysis of tissue protein expression in breast cancer,"HR Ali, M Irwin, L Morris, SJ Dawson, FM Blows, E Provenzano, ...","British journal of cancer 108 (3), 602",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5134923266622461176,35,2013
High-resolution array-based comparative genomic hybridization of bladder cancers identifies mouse double minute 4 (MDM4) as an amplification target exclusive of MDM2 and TP53,"A Veerakumarasivam, HE Scott, SF Chin, A Warren, MJ Wallard, ...","Clinical Cancer Research 14 (9), 2527-2534",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17753383761477165941,35,2008
Neo-tAnGo: A neoadjuvant randomized phase III trial of epirubicin/cyclophosphamide and paclitaxel±gemcitabine in the treatment of women with high-risk early breast cancer (EBC …,"HM Earl, A Vallier, L Hiller, N Fenwick, M Iddawela, L Hughes-Davies, ...","Journal of Clinical Oncology 27 (15_suppl), 522-522",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13497339272334513939,34,2009
Small molecule inhibition of group I p21-activated kinases in breast cancer induces apoptosis and potentiates the activity of microtubule stabilizing agents,"CC Ong, S Gierke, C Pitt, M Sagolla, CK Cheng, W Zhou, AM Jubb, ...","Breast Cancer Research 17 (1), 59",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16628684933297333671,33,2015
The impact of prophylactic total gastrectomy on health-related quality of life: a prospective cohort study,"E Worster, X Liu, S Richardson, RH Hardwick, S Dwerryhouse, C Caldas, ...","Annals of surgery 260 (1), 87-93",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2416598325182930048,33,2014
The breast cancer somatic'muta-ome': tackling the complexity,"AE Teschendorff, C Caldas","Breast Cancer Research 11 (2), 301",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2536714674430008776,33,2009
"Expression and protein-binding studies of the EEN gene family, new interacting partners for dynamin, synaptojanin and huntingtin proteins","CW SO, MH SHAM, SL CHEW, N CHEUNG, KC Cary, SK CHUNG, ...","Biochemical Journal 348 (2), 447-458",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15257738607435313354,33,2000
Isolation and characterization of a pufferfish MLL (mixed lineage leukemia)-like gene (fMll) reveals evolutionary conservation in vertebrate genes related to Drosophila trithorax,"C Caldas, MH Kim, A MacGregor, D Cain, S Aparicio, LM Wiedemann","Oncogene 16 (25), 3233",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4993341654682573143,33,1998
Lymphocyte invasion in IC10/basal-like breast tumors is associated with wild-type TP53,"D Quigley, L Silwal-Pandit, R Dannenfelser, A Langerød, HKM Vollan, ...","Molecular Cancer Research 13 (3), 493-501",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17182698237676796703,32,2015
Oncogenic ,"A Obrador‐Hevia, SF Chin, S González, J Rees, F Vilardell, JK Greenson, ...","The Journal of pathology 221 (1), 57-67",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6153080169012363597,32,2010
Extent of differential allelic expression of candidate breast cancer genes is similar in blood and breast,"AT Maia, I Spiteri, AJX Lee, M O'Reilly, L Jones, C Caldas, BAJ Ponder","Breast cancer research 11 (6), R88",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5871364288744668016,32,2009
Effects of common germline genetic variation in cell cycle control genes on breast cancer survival: results from a population-based cohort,"EM Azzato, KE Driver, F Lesueur, M Shah, D Greenberg, DF Easton, ...","Breast Cancer Research 10 (3), R47",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7781818944059400995,32,2008
Co‐amplification of 8p12 and 11q13 in breast cancers is not the result of a single genomic event,"AL Paterson, JCM Pole, KA Blood, MJ Garcia, SL Cooke, AE Teschendorff, ...","Genes, Chromosomes and Cancer 46 (5), 427-439",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17744521059306569956,32,2007
Telomerase-and alternative telomere lengthening–independent telomere stabilization in a metastasis-derived human non–small cell lung cancer cell line: effect of ectopic hTERT,"A Brachner, S Sasgary, C Pirker, C Rodgarkia, M Mikula, W Mikulits, ...","Cancer research 66 (7), 3584-3592",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8896109100692957854,32,2006
Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancer,"N Ben-Chetrit, D Chetrit, R Russell, C Körner, M Mancini, A Abdul-Hai, ...","Sci. Signal. 8 (360), ra7-ra7",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13831994539013489799,31,2015
A tumor DNA complex aberration index is an independent predictor of survival in breast and ovarian cancer,"HKM Vollan, OM Rueda, SF Chin, C Curtis, G Turashvili, S Shah, ...","Molecular oncology 9 (1), 115-127","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4226474533017310145,7690211033888413834",31,2015
A central review of histopathology reports after breast cancer neoadjuvant chemotherapy in the neo-tango trial,"E Provenzano, AL Vallier, R Champ, K Walland, S Bowden, A Grier, ...","British journal of cancer 108 (4), 866-872",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8590364383461302223,31,2013
Assignment of the E-cadherin gene (CDH1) to chromosome 16q22. 1 by radiation hybrid mapping,"DG Huntsman, C Caldas","Cytogenetic and Genome Research 83 (1-2), 82",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17111789174310470026,31,1998
Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer,"HR Ali, A Dariush, E Provenzano, H Bardwell, JE Abraham, M Iddawela, ...","Breast Cancer Research 18 (1), 21",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3404932800632751629,30,2016
A prognostic gene signature for metastasis-free survival of triple negative breast cancer patients,"UJ Lee, C Frankenberger, J Yun, E Bevilacqua, C Caldas, SF Chin, ...","PLoS One 8 (12), e82125",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16779444763948686931,30,2013
A sparse regulatory network of copy-number driven gene expression reveals putative breast cancer oncogenes,"Y Yuan, C Curtis, C Caldas, F Markowetz","IEEE/ACM transactions on computational biology and bioinformatics 9 (4), 947-954",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15977062112462183991,30,2011
"PMC42, a breast progenitor cancer cell line, has normal-like mRNA and microRNA transcriptomes","A Git, I Spiteri, C Blenkiron, MJ Dunning, JCM Pole, SF Chin, Y Wang, ...","Breast Cancer Research 10 (3), R54",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7003019481747173334,30,2008
Metabolic consequences of p300 gene deletion in human colon cancer cells,"JG Bundy, NG Iyer, MS Gentile, DE Hu, M Kettunen, AT Maia, NP Thorne, ...","Cancer research 66 (15), 7606-7614",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12037533094860958323,30,2006
Therapeutic relevance of the PP2A-B55 inhibitory kinase MASTL/Greatwall in breast cancer,"M Álvarez-Fernández, M Sanz-Flores, B Sanz-Castillo, M Salazar-Roa, ...","Cell Death & Differentiation, 1-13",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3797095378873106835,29,2017
It's PRIMETIME. Postoperative avoidance of radiotherapy: biomarker selection of women at very low risk of local recurrence,"CC Kirwan, CE Coles, J Bliss, C Kirwan, L Kilburn, L Fox, M Cheang, ...","Clinical Oncology 28 (9), 594-596",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8945591777942287930,29,2016
Tamoxifen: the drug that came in from the cold,"L Hughes-Davies, C Caldas, GC Wishart","British journal of cancer 101 (6), 875-878",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9062892988380893014,29,2009
p400 function is required for the adenovirus E1A-mediated suppression of EGFR and tumour cell killing,"MB Flinterman, JS Mymryk, P Klanrit, AF Yousef, SW Lowe, C Caldas, ...","Oncogene 26 (48), 6863",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5919992634188901342,29,2007
Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome,"MR Aure, V Vitelli, S Jernström, S Kumar, M Krohn, EU Due, TH Haukaas, ...","Breast Cancer Research 19 (1), 44",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6435169206741115111,28,2017
PDX-MI: minimal information for patient-derived tumor xenograft models,"TF Meehan, N Conte, T Goldstein, G Inghirami, MA Murakami, S Brabetz, ...","Cancer research 77 (21), e62-e66",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10249795966705986123,28,2017
Subtype‐specific micro‐RNA expression signatures in breast cancer progression,"VD Haakensen, V Nygaard, L Greger, MR Aure, B Fromm, IRK Bukholm, ...","International journal of cancer 139 (5), 1117-1128",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16255471256441796319,28,2016
A general procedure to combine estimators,"F Lavancier, P Rochet","Computational Statistics & Data Analysis 94, 175-192",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8834485969952792002,28,2016
Cancer Core Europe: A consortium to address the cancer care–Cancer research continuum challenge,"AMM Eggermont, C Caldas, U Ringborg, R Medema, J Tabernero, ...","European Journal of Cancer 50 (16), 2745-2746",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2043560690330334209,28,2014
ICGC PedBrain,"LB Alexandrov, S Nik-Zainal, DC Wedge","Signatures of mutational processes in human cancer. Nature 500 (7463), 415-421","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6778619844142363303,562471667058249935",28,2013
Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups,"OM Rueda, SJ Sammut, JA Seoane, SF Chin, JL Caswell-Jin, M Callari, ...","Nature 567 (7748), 399",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10196136466218565018,27,2019
Amplification of TRIM44: pairing a prognostic target with potential therapeutic strategy,"CAJ Ong, NB Shannon, CS Ross-Innes, M O’Donovan, OM Rueda, D Hu, ...","Journal of the National Cancer Institute 106 (5), dju050",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16821266210625317811,27,2014
Common germline polymorphisms associated with breast cancer-specific survival,"A Pirie, Q Guo, P Kraft, S Canisius, DM Eccles, N Rahman, H Nevanlinna, ...","Breast cancer research 17 (1), 58",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15342655595746175183,26,2015
Familial gastric cancer–clinical management,"RC Fitzgerald, C Caldas","Best Practice & Research Clinical Gastroenterology 20 (4), 735-743",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4019346305495716717,26,2006
Therapeutic rationale to target highly expressed CDK7 conferring poor outcomes in triple-negative breast cancer,"B Li, TN Chonghaile, Y Fan, SF Madden, R Klinger, AE O'Connor, ...","Cancer research 77 (14), 3834-3845",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16842298330928245470,25,2017
Zucman-Rossi J,"LB Alexandrov, S Nik-Zainal, DC Wedge, SA Aparicio, S Behjati, ...","Futreal PA, McDermott U, Lichter P, Meyerson M, Grimmond SM, Siebert R …",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7664035292642917033,25,2013
One-stop diagnostic breast clinics: how often are breast cancers missed?,"P Britton, SW Duffy, R Sinnatamby, MG Wallis, S Barter, M Gaskarth, ...","British journal of cancer 100 (12), 1873",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15465429901721155082,25,2009
Molecular genetics and the assessment of human cancers.,"PD Pharoah, C Caldas","Expert reviews in molecular medicine 1999, 1-19","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12051898230000391080,779867783831584168",25,1999
Comparative study of endoscopic surveillance in hereditary diffuse gastric cancer according to CDH1 mutation status,"EZ Mi, EZ Mi, M di Pietro, M O’Donovan, RH Hardwick, S Richardson, ...","Gastrointestinal endoscopy 87 (2), 408-418",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13191905810623656374,24,2018
Intra-tumour signalling entropy determines clinical outcome in breast and lung cancer,"CRS Banerji, S Severini, C Caldas, AE Teschendorff","PLoS computational biology 11 (3), e1004115",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10906035627891551756,24,2015
Breast cancer susceptibility risk associations and heterogeneity by E-cadherin tumor tissue expression,"HN Horne, ME Sherman, M Garcia-Closas, PD Pharoah, FM Blows, ...","Breast cancer research and treatment 143 (1), 181-187",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3620494981972971315,24,2014
Genomic analysis of the 8p11‐12 amplicon in familial breast cancer,"L Melchor, MJ Garcia, E Honrado, JCM Pole, S Alvarez, PAW Edwards, ...","International journal of cancer 120 (3), 714-717",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12444796745338432769,24,2007
Androgen and estrogen receptors in breast cancer coregulate human UDP-glucuronosyltransferases 2B15 and 2B17,"DG Hu, LA Selth, GA Tarulli, R Meech, D Wijayakumara, A Chanawong, ...","Cancer research 76 (19), 5881-5893",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10704750236095950985,23,2016
Calpastatin is associated with lymphovascular invasion in breast cancer,"SJ Storr, RAA Mohammed, CM Woolston, AR Green, T Parr, I Spiteri, ...","The Breast 20 (5), 413-418",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15608431048702833332,23,2011
"ZNF198, a zinc finger protein rearranged in myeloproliferative disease, localizes to the PML nuclear bodies and interacts with SUMO-1 and PML","P Kunapuli, CS Kasyapa, SF Chin, C Caldas, JK Cowell","Experimental cell research 312 (19), 3739-3751",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9315930070068614843,23,2006
Rosai-Dorfman disease of the testis: an unusual entity that mimics testicular malignancy,"SM Fernandopulle, JSG Hwang, CH Kuick, J Lui, PH Tan, WY Siow, ...","Journal of clinical pathology 59 (3), 325-327","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16625207461232725347,14633888500041349333",23,2006
Molecular forecasting of breast cancer: time to move forward with clinical testing,"S Loi, C Sotiriou, M Buyse, E Rutgers, LV Veer, M Piccart, F Cardoso","Journal of clinical oncology 24 (4), 721-722",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17361626408517949603,23,2006
Cancer genes and molecular oncology in the clinic,"C Caldas, BAJ Ponder","The Lancet 349, S16-S18",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2407562325281876829,23,1997
Determining risk of Barrett’s esophagus and esophageal adenocarcinoma based on epidemiologic factors and genetic variants,"J Dong, MF Buas, P Gharahkhani, BJ Kendall, L Onstad, S Zhao, ...","Gastroenterology 154 (5), 1273-1281. e3",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3479398180953989273,22,2018
Pathway-based personalized analysis of breast cancer expression data,"A Livshits, A Git, G Fuks, C Caldas, E Domany","Molecular oncology 9 (7), 1471-1483",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12401573367329851047,22,2015
TOMM34 expression in early invasive breast cancer: a biomarker associated with poor outcome,"MA Aleskandarany, OH Negm, EA Rakha, MAH Ahmed, CC Nolan, ...","Breast cancer research and treatment 136 (2), 419-427",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11182321681994881878,22,2012
From genomic landscapes to personalized cancer management—is there a roadmap?,"C Swanton, C Caldas","Annals of the New York Academy of Sciences 1210 (1), 34-44",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4743489791359825453,22,2010
A novel mutation in the E-cadherin gene in the first family with hereditary diffuse gastric cancer reported in Spain,"JC Rodriguez-Sanjuan, A Fontalba, M Mayorga, MC Bordin, SJ Hyland, ...","European Journal of Surgical Oncology (EJSO) 32 (10), 1110-1113",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7144117622850351691,22,2006
Does massively parallel transcriptome analysis signify the end of cancer histopathology as we know it?,"SAJR Aparicio, C Caldas, B Ponder","Genome biology 1 (3), reviews1021. 1",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7973153515318592188,22,2000
The BRCA1 ness signature is associated significantly with response to PARP inhibitor treatment versus control in the I-SPY 2 randomized neoadjuvant setting,"TM Severson, DM Wolf, C Yau, J Peeters, D Wehkam, PC Schouten, ...","Breast Cancer Research 19 (1), 99",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12613420540937187115,21,2017
Intersect-then-combine approach: improving the performance of somatic variant calling in whole exome sequencing data using multiple aligners and callers,"M Callari, SJ Sammut, L De Mattos-Arruda, A Bruna, OM Rueda, SF Chin, ...","Genome medicine 9 (1), 35",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10674995917676179554,21,2017
Context-specific effects of TGF-β/SMAD3 in cancer are modulated by the epigenome,"AT Vidakovic, OM Rueda, SJ Vervoort, AS Batra, MA Goldgraben, ...","Cell reports 13 (11), 2480-2490",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15003021960067147715,21,2015
"DNA polymerase β deficiency is linked to aggressive breast cancer: A comprehensive analysis of gene copy number, mRNA and protein expression in multiple cohorts","TMA Abdel-Fatah, R Russell, D Agarwal, P Moseley, MA Abayomi, ...","Molecular oncology 8 (3), 520-532",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13039338378988582048,21,2014
TOX3 mutations in breast cancer,"JO Jones, SF Chin, LA Wong-Taylor, D Leaford, BAJ Ponder, C Caldas, ...","PloS one 8 (9), e74102",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=163799378196913660,21,2013
Chromosome 17 polysomy (Ch17) as a predictor of anthracycline response: emerging evidence from the UK ,"J Bartlett, A Munro, J Dunn, L Hiller, S Jordan, C Twelves, D Cameron, ...","Cancer Research 69 (2 Supplement), 45",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4089819621385797020,21,2009
Epstein-Barr virus and bone marrow transplantation.,"C Caldas, R Ambinder","Current opinion in oncology 7 (2), 102-106",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7899608323256432315,21,1995
The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper,"M Cristofanilli, JY Pierga, J Reuben, A Rademaker, AA Davis, DJ Peeters, ...",Critical reviews in oncology/hematology,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11013978769780503712,20,2018
MAP3K1 and MAP2K4 mutations are associated with sensitivity to MEK inhibitors in multiple cancer models,"Z Xue, DJ Vis, A Bruna, T Sustic, S van Wageningen, AS Batra, ...","Cell research 28 (7), 719",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1281932390845728935,20,2018
Multidisciplinary decisions in breast cancer: does the patient receive what the team has recommended?,"S Rajan, J Foreman, MG Wallis, C Caldas, P Britton","British journal of cancer 108 (12), 2442",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9588551567290290267,20,2013
A metadata approach for clinical data management in translational genomics studies in breast cancer,"I Papatheodorou, C Crichton, L Morris, P Maccallum, J Davies, ...","BMC Medical Genomics 2 (1), 66",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4746851019998122797,20,2009
Germline variation in inflammation-related pathways and risk of Barrett's oesophagus and oesophageal adenocarcinoma,"MF Buas, Q He, LG Johnson, L Onstad, DM Levine, AP Thrift, ...","Gut 66 (10), 1739-1747",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13058108485507875614,19,2017
Weibull regression with Bayesian variable selection to identify prognostic tumour markers of breast cancer survival,"PJ Newcombe, H Raza Ali, FM Blows, E Provenzano, PD Pharoah, ...","Statistical methods in medical research 26 (1), 414-436",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16758324791529833076,19,2017
"Imprinted chromatin around DIRAS3 regulates alternative splicing of GNG12-AS1, a long noncoding RNA","M Niemczyk, Y Ito, J Huddleston, A Git, S Abu-Amero, C Caldas, ...","The American Journal of Human Genetics 93 (2), 224-235",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15101274021300453795,19,2013
Gas-insulated switchgear device,"C Piazza, G Guerra","US Patent 6,683,267","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2701765185076738884,3204505621339287749",19,2004
Predictive cancer genomics—what do we need?,"JD Brenton, C Caldas","The Lancet 362 (9381), 340-341",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16521106734163140989,19,2003
A RAD 51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation,"M Castroviejo‐Bermejo, C Cruz, A Llop‐Guevara, S Gutiérrez‐Enríquez, ...","EMBO molecular medicine 10 (12), e9172",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2944425091844407470,18,2018
Double-stranded microRNA mimics can induce length-and passenger strand–dependent effects in a cell type–specific manner,"MA Goldgraben, R Russell, OM Rueda, C Caldas, A Git","Rna 22 (2), 193-203",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2857020315906163010,18,2016
Up‐regulation of the interferon‐related genes in ,"H Xu, J Xian, E Vire, S McKinney, V Wei, J Wong, R Tong, T Kouzarides, ...","The Journal of pathology 234 (3), 386-397",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8391373518391219743,18,2014
Differential gene expression profile in the small intestines of mice lacking pacemaker interstitial cells of Cajal,"Y Daigo, I Takayama, BAJ Ponder, C Caldas, SM Ward, KM Sanders, ...","BMC gastroenterology 3 (1), 17",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9508024959224772894,18,2003
Molecular assessment of cancer,C Caldas,"Bmj 316 (7141), 1360",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9715656334508869613,18,1998
Effects of collection and processing procedures on plasma circulating cell-free DNA from cancer patients,"B Risberg, DWY Tsui, H Biggs, ARVM de Almagro, SJ Dawson, ...","The Journal of Molecular Diagnostics 20 (6), 883-892",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9546763647717546463,17,2018
An investigation of the factors effecting high-risk individuals’ decision-making about prophylactic total gastrectomy and surveillance for hereditary diffuse gastric cancer (HDGC),"N Hallowell, S Badger, S Richardson, C Caldas, RH Hardwick, ...","Familial cancer 15 (4), 665-676",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10541593479984455357,17,2016
Robust BRCA1-like classification of copy number profiles of samples repeated across different datasets and platforms,"PC Schouten, A Grigoriadis, T Kuilman, H Mirza, JA Watkins, SA Cooke, ...","Molecular oncology 9 (7), 1274-1286",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2421435195236072274,17,2015
Basic cancer research is essential for the success of personalised medicine,"Y Yarden, C Caldes","European journal of cancer 49 (12), 2619-2620","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11512764676107725131,16990587238869387743",17,2013
Germline pathogenic variants in PALB2 and other cancer-predisposing genes in families with hereditary diffuse gastric cancer without CDH1 mutation: a whole-exome sequencing study,"E Fewings, A Larionov, J Redman, MA Goldgraben, J Scarth, ...","The Lancet Gastroenterology & Hepatology 3 (7), 489-498",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1744289189967914723,16,2018
Stratification and therapeutic potential of PML in metastatic breast cancer,"N Martín-Martín, M Piva, J Urosevic, P Aldaz, JD Sutherland, ...","Nature communications 7, 12595",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11168236912180038806,16,2016
"Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium","WJ Howat, FM Blows, E Provenzano, MN Brook, L Morris, P Gazinska, ...","The Journal of Pathology: Clinical Research 1 (1), 18-32",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7179293528923513035,16,2015
Prognosis of early breast cancer by immunohistochemistry defined intrinsic sub‐types in patients treated with adjuvant chemotherapy in the NEAT/BR9601 trial,"AM Ali, E Provenzano, JMS Bartlett, J Abraham, K Driver, AF Munro, ...","International journal of cancer 133 (6), 1470-1478",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4218035553785534347,16,2013
Common germ-line polymorphism of ,"EM Azzato, AJX Lee, A Teschendorff, BAJ Ponder, P Pharoah, C Caldas, ...","British journal of cancer 102 (8), 1294",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12604948698628949142,16,2010
Computational approach to discriminate human and mouse sequences in patient-derived tumour xenografts,"M Callari, AS Batra, RN Batra, SJ Sammut, W Greenwood, H Clifford, ...","BMC genomics 19 (1), 19",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11993395660728506910,15,2018
Dynamics of multiple resistance mechanisms in plasma DNA during EGFR‐targeted therapies in non‐small cell lung cancer,"DWY Tsui, M Murtaza, ASC Wong, OM Rueda, CG Smith, ...",EMBO molecular medicine 10 (6),https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14890315910329895478,15,2018
Expression profiling of nuclear receptors in breast cancer identifies TLX as a mediator of growth and invasion in triple-negative breast cancer,"ML Lin, H Patel, J Remenyi, CRS Banerji, CF Lai, M Periyasamy, ...","Oncotarget 6 (25), 21685",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9626679306430135508,15,2015
"Navigator‐3, a modulator of cell migration, may act as a suppressor of breast cancer progression","H Cohen‐Dvashi, N Ben‐Chetrit, R Russell, S Carvalho, M Lauriola, ...","EMBO molecular medicine 7 (3), 299-314",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6084612854890843747,15,2015
Lack of expression of the proteins GMPR2 and PPARα are associated with the basal phenotype and patient outcome in breast cancer,"BG Baker, GR Ball, EA Rakha, CC Nolan, C Caldas, IO Ellis, AR Green","Breast cancer research and treatment 137 (1), 127-137",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11194589944616074742,15,2013
Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers,"AT Maia, AC Antoniou, M O'Reilly, S Samarajiwa, M Dunning, ...","Breast cancer research 14 (2), R63",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16220969530032439310,15,2012
Hereditary diffuse gastric cancer: More answers or more questions?,"WM Grady, RM Peek Jr","Gastroenterology 122 (3), 830-831",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16486818124256752104,15,2002
Biliopancreatic malignancy: screening the at risk patient with molecular markers,C Caldas,"Annals of oncology 10 (suppl_4), S153-S156",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17730746125930666489,15,1999
Prognostic Value of MammaPrint,"IJ Beumer, M Persoon, A Witteveen, C Dreezen, SF Chin, SJ Sammut, ...","Biomarker insights 11, BMI. S38435",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13090086018102776820,14,2016
Assessing excellence in translational cancer research: a consensus based framework,"A Rajan, C Caldas, H van Luenen, M Saghatchian, WH van Harten","Journal of translational medicine 11 (1), 274",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4858271410763152692,14,2013
"A nested cohort study of 6,248 early breast cancer patients treated in neoadjuvant and adjuvant chemotherapy trials investigating the prognostic value of chemotherapy-related …","JE Abraham, L Hiller, L Dorling, AL Vallier, J Dunn, S Bowden, S Ingle, ...","BMC medicine 13 (1), 306",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=92124995699930693,13,2015
The importance of platform annotation in interpreting microarray data,"MJ Dunning, C Curtis, NL Barbosa-Morais, C Caldas, S Tavaré, AG Lynch","The lancet oncology 11 (8), 717",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2123146635986061258,13,2010
Analysis of the region of the 5′ end of the ,"LM Wiedemann, A MacGregor, C Caldas","British journal of haematology 105 (1), 256-264",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16508580829437333569,13,1999
6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial,"HM Earl, L Hiller, AL Vallier, S Loi, K McAdam, L Hughes-Davies, ...",The Lancet,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10121998469098993826,12,2019
High USP6NL levels in breast cancer sustain chronic AKT phosphorylation and GLUT1 stability fueling aerobic glycolysis,"D Avanzato, E Pupo, N Ducano, C Isella, G Bertalot, C Luise, S Pece, ...","Cancer research 78 (13), 3432-3444","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11333817342988828067,3055219443222467942",12,2018
Body mass index and breast cancer survival: a Mendelian randomization analysis,"Q Guo, S Burgess, C Turman, MK Bolla, Q Wang, M Lush, J Abraham, ...","International journal of epidemiology 46 (6), 1814-1822",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3750439677355932089,12,2017
"Disease-free and overall survival at 3.5 years for neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin and cyclophosphamide, for women with HER2 …","HM Earl, L Hiller, JA Dunn, C Blenkinsop, L Grybowicz, AL Vallier, ...","Annals of Oncology 28 (8), 1817-1824",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7896305068620007795,12,2017
The breast cancer genome-a key for better oncology,"HKM Vollan, C Caldas","BMC cancer 11 (1), 501",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13621834036590807377,12,2011
The psychosocial impact of undergoing prophylactic total gastrectomy (PTG) to manage the risk of hereditary diffuse gastric cancer (HDGC),"N Hallowell, J Lawton, S Badger, S Richardson, RH Hardwick, C Caldas, ...","Journal of genetic counseling 26 (4), 752-762",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17313848413396948636,11,2017
"Adjuvant epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) ","HM Earl, L Hiller, JA Dunn, AL Vallier, SJ Bowden, SD Jordan, F Blows, ...","British journal of cancer 107 (8), 1257",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14543811902233452779,11,2012
Molecular staging of cancer: is it time?,C Caldas,"The Lancet 350 (9073), 231",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2094189044859787515,11,1997
Predicting treatment resistance and relapse through circulating DNA,"E Beddowes, SJ Sammut, M Gao, C Caldas","The Breast 34, S31-S35",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1286402828616937896,10,2017
Ki67 expression in invasive breast cancer: the use of tissue microarrays compared with whole tissue sections,"AA Muftah, MA Aleskandarany, MM Al-Kaabi, SN Sonbul, ...","Breast cancer research and treatment 164 (2), 341-348",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13132256026375816929,10,2017
"Addition of gemcitabine to paclitaxel, epirubicin, and cyclophosphamide adjuvant chemotherapy for women with early-stage breast cancer (tAnGo): final 10-year follow-up of an …","HM Earl, L Hiller, HC Howard, JA Dunn, J Young, SJ Bowden, ...","The Lancet Oncology 18 (6), 755-769",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5040583598707150195,10,2017
Lymphocyte density determined by computational pathology validated as a predictor of response to neoadjuvant chemotherapy in breast cancer: secondary analysis of the ARTemis trial,"HR Ali, A Dariush, J Thomas, E Provenzano, J Dunn, L Hiller, AL Vallier, ...","Annals of Oncology 28 (8), 1832-1835",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15198142808944064665,10,2017
Allele-specific expression analysis methods for high-density SNP microarray data,"R Liu, AT Maia, R Russell, C Caldas, BA Ponder, ME Ritchie","Bioinformatics 28 (8), 1102-1108",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4405089831908788817,10,2012
CYP2D6 gene variants and their association with breast cancer susceptibility,"JE Abraham, MJ Maranian, KE Driver, R Platte, B Kalmyrzaev, C Baynes, ...","Cancer Epidemiology and Prevention Biomarkers 20 (6), 1255-1258",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5963198137982914183,10,2011
"Bergenin monohydrate, a constituent of Hurmiria balsamifera, at 120 K","CS Caldas, CA De Simone, MA Pereira, VRS Malta, RLP Carvalho, ...","Acta Crystallographica Section E: Structure Reports Online 58 (6), o609-o611",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14325435444513106729,10,2002
Taxol in epithelial ovarian cancer.,C Caldas,"Journal of the National Cancer Institute. Monographs, 155-159",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9357180635482519336,10,1993
The circular RNome of primary breast cancer,"M Smid, SM Wilting, K Uhr, FG Rodríguez-González, V De Weerd, ...","Genome research 29 (3), 356-366",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3815455303246598505,9,2019
p120-catenin prevents multinucleation through control of MKLP1-dependent RhoA activity during cytokinesis,"RA Van De Ven, JS De Groot, D Park, R Van Domselaar, D De Jong, ...","Nature communications 7, 13874",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14208850081561141974,9,2016
Genetics: How to validate a breast cancer prognostic signature,"PD Pharoah, C Caldas","Nature Reviews Clinical Oncology 7 (11), 615",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12621253119364943742,9,2010
Comparative genomic hybridization using DNA from laser capture microdissected tissue,"G Callagy, L Jackson, C Caldas","Laser Capture Microdissection, 40-56",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4379110657557385193,9,2005
"Novel human, mouse and xenopus genes encoding a member of the RAS superfamily of low‐molecular‐weight GTP‐binding proteins and its downregulation in W/WV mouse jejunum","Y Daigo, I Takayama, BA Ponder, C Caldas, SM Ward, KM Sanders, ...","Journal of gastroenterology and hepatology 19 (2), 211-217",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13063409695537374056,9,2004
Absence of rearrangements in the ,"SF Chin, Q Wang, A Puisieux, C Caldas","British journal of cancer 84 (2), 193",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5525721466628374330,9,2001
Cancer Core Europe: a translational research infrastructure for a European mission on cancer,"AMM Eggermont, G Apolone, M Baumann, C Caldas, JE Celis, ...","Molecular oncology 13 (3), 521-527",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16164517605320468996,8,2019
Cancer Core Europe: A European cancer research alliance realizing a research infrastructure with critical mass and programmatic approach to cure cancer in the 21st century,"F Calvo, G Apolone, M Baumann, C Caldas, JE Celis, F de Lorenzo, ...","European Journal of Cancer 103, 155-159",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15612937727440181207,8,2018
SOX4 can redirect TGF-β-mediated SMAD3-transcriptional output in a context-dependent manner to promote tumorigenesis,"SJ Vervoort, AR Lourenço, A Tufegdzic Vidakovic, E Mocholi, ...","Nucleic acids research 46 (18), 9578-9590",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13321016033662926407,8,2018
Shallow whole genome sequencing for robust copy number profiling of formalin-fixed paraffin-embedded breast cancers,"SF Chin, A Santonja, M Grzelak, S Ahn, SJ Sammut, H Clifford, OM Rueda, ...","Experimental and molecular pathology 104 (3), 161-169",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10486809820033370914,8,2018
"Data-driven analysis of immune infiltrate in a large cohort of breast cancer and its association with disease progression, ER activity, and genomic complexity","R Dannenfelser, M Nome, A Tahiri, J Ursini-Siegel, HKM Vollan, ...","Oncotarget 8 (34), 57121",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9051388508872256760,8,2017
Calling sample mix-ups in cancer population studies,"AG Lynch, SF Chin, MJ Dunning, C Caldas, S Tavaré, C Curtis","PLoS One 7 (8), e41815",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12091365979561820301,8,2012
SILAC identifies LAD1 as a filamin-binding regulator of actin dynamics in response to EGF and a marker of aggressive breast tumors,"L Roth, S Srivastava, M Lindzen, A Sas-Chen, M Sheffer, M Lauriola, ...","Sci. Signal. 11 (515), eaan0949",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=398533456351550820,7,2018
Integrative analysis of copy number and gene expression in breast cancer using formalin-fixed paraffin-embedded core biopsy tissue: a feasibility study,"M Iddawela, O Rueda, J Eremin, O Eremin, J Cowley, HM Earl, C Caldas","BMC genomics 18 (1), 526",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15779492807167811347,7,2017
Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancer,"Z Hu, JH Mao, C Curtis, G Huang, S Gu, L Heiser, ME Lenburg, ...","Breast Cancer Research 18 (1), 70",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14269084286524008443,7,2016
"The C/EBPδ protein is stabilized by estrogen receptor α activity, inhibits ","D Mendoza-Villanueva, K Balamurugan, HR Ali, SR Kim, S Sharan, ...","Oncogene 35 (48), 6166",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15719704919058300764,7,2016
Nucleosome mapping in plasma DNA predicts cancer gene expression,"M Murtaza, C Caldas","Nature genetics 48 (10), 1105",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9377170735843287338,7,2016
Nuclear CSPP1 expression defined subtypes of basal-like breast cancer,"J Sternemalm, HG Russnes, X Zhao, B Risberg, S Nord, C Caldas, ...","British journal of cancer 111 (2), 326",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13539668769139170552,7,2014
"a JR, Behjati S, Biankin AV, et al","LB Alexandrov, S Nik-Zainal, DC Wedge, S Aparicio","Signatures of mutational processes in human cancer. Nature 500, 415-21",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3587805110248737984,7,2013
Optimal amounts of fluorescent dye improve expression microarray results in tumor specimens,"A Naderi, AA Ahmed, Y Wang, JD Brenton, C Caldas","Molecular biotechnology 30 (2), 151-154",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5713652293949019218,7,2005
MTAP homozygous deletion: an Achilles heel of human cancers ready for clinical use?,"G Capella, C Caldas","Cancer biology & therapy 4 (3), 347-347",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18171676716862026349,7,2005
Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer,"BR McDonald, T Contente-Cuomo, SJ Sammut, A Odenheimer-Bergman, ...","Science translational medicine 11 (504), eaax7392",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9870760979902640755,6,2019
Central pathology review with two-stage quality assurance for pathological response after neoadjuvant chemotherapy in the ARTemis trial,"JSJ Thomas, E Provenzano, L Hiller, J Dunn, C Blenkinsop, L Grybowicz, ...","Modern Pathology 30 (8), 1069",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15978447391225106398,6,2017
"Reliable gene expression profiling of formalin-fixed paraffin-embedded breast cancer tissue (FFPE) using cDNA-mediated annealing, extension, selection, and ligation whole …","M Iddawela, OM Rueda, M Klarqvist, S Graf, HM Earl, C Caldas","BMC medical genomics 9 (1), 54",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14860175299404475919,6,2016
Polymorphisms in genes of relevance for oestrogen and oxytocin pathways and risk of Barrett’s oesophagus and oesophageal adenocarcinoma: a pooled analysis from the BEACON …,"K Lagergren, WE Ek, D Levine, WH Chow, L Bernstein, AG Casson, ...","PloS one 10 (9), e0138738",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2763633737695776473,6,2015
eEF2K—a new target in breast cancers with combined inactivation of p53 and PTEN,"HG Russnes, C Caldas","EMBO molecular medicine 6 (12), 1512-1514",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14352500953073855009,6,2014
"ARTemis: A randomised trial of bevacizumab with neoadjuvant chemotherapy (NACT) for patients with HER2-negative early breast cancer—Primary endpoint, pathological complete …","HM Earl, L Hiller, C Blenkinsop, L Grybowicz, AL Vallier, J Abraham, ...","Journal of Clinical Oncology 32 (15_suppl), 1014-1014",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6966923988036653243,6,2014
Salvage therapy in epithelial ovarian cancer.,"C Caldas, LE Morris","Obstetrics and gynecology clinics of North America 21 (1), 179-194",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17698629706058727162,6,1994
Intratumoral Adaptive Immunosuppression and Type 17 Immunity in Mismatch Repair Proficient Colorectal Tumors,"NJ Llosa, B Luber, AJ Tam, KN Smith, N Siegel, AH Awan, H Fan, T Oke, ...",Clinical Cancer Research,"https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11702304765200823755,16302764703129181968,12943693896301893062",5,2019
Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy,"JL Caswell-Jin, K McNamara, JG Reiter, R Sun, Z Hu, Z Ma, J Ding, ...","Nature communications 10 (1), 657",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1167526422558924241,5,2019
Associations between genomic stratification of breast cancer and centrally reviewed tumour pathology in the METABRIC cohort,"A Mukherjee, R Russell, SF Chin, B Liu, OM Rueda, HR Ali, G Turashvili, ...","NPJ breast cancer 4 (1), 5",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12101398509664103954,5,2018
Rho-GTPase activating-protein 18: a biomarker associated with good prognosis in invasive breast cancer,"MA Aleskandarany, S Sonbul, R Surridge, A Mukherjee, C Caldas, ...","British journal of cancer 117 (8), 1176",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12957172720536414544,5,2017
Further evidence to support bimodality of oestrogen receptor expression in breast cancer,"AA Muftah, M Aleskandarany, SN Sonbul, CC Nolan, M Diez Rodriguez, ...","Histopathology 70 (3), 456-465",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10401771988949855859,5,2017
POSEIDON trial phase 1b results: Safety and preliminary efficacy of the isoform selective PI3K inhibitor taselisib (GDC-0032) combined with tamoxifen in hormone receptor (HR …,"RD Baird, A Van Rossum, M Oliveira, K Beelen, J Garcia-Corbacho, ...","Journal of Clinical Oncology 34 (15_suppl), 2520-2520",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14524065436638308775,5,2016
Excellent translational research in oncology: a journey towards novel and more effective anti‐cancer therapies,"A Rajan, A Berns, U Ringborg, J Celis, B Ponder, C Caldas, D Livingston, ...","Molecular oncology 10 (5), 645-651",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11601987627313739745,5,2016
Pancreatic cancer,"HY Leung, NR Lemoine","Cancer: a molecular approach, 105-115",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4730886094293452111,5,1994
Next Generation-Targeted Amplicon Sequencing (NG-TAS): an optimised protocol and computational pipeline for cost-effective profiling of circulating tumour DNA,"M Gao, M Callari, E Beddowes, SJ Sammut, M Grzelak, H Biggs, L Jones, ...","Genome medicine 11 (1), 1",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16673939615235730637,4,2019
miR-342-5p as a Potential Regulator of HER2 Breast Cancer Cell Growth,"EM Lindholm, SK Leivonen, E Undlien, D Nebdal, A Git, C Caldas, ...","MicroRNA 8 (2), 155-165",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15896457413013465974,4,2019
Cancer treatment in the genomic era,"GJ Doherty, M Petruzzelli, E Beddowes, SS Ahmad, C Caldas, ...","Annual review of biochemistry 88, 247-280",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2003727360450059865,4,2019
Global transcriptional analysis identifies a novel role for SOX4 in tumor-induced angiogenesis,"SJ Vervoort, OG de Jong, MG Roukens, CL Frederiks, JF Vermeulen, ...","Elife 7, e27706",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8988359476229655617,4,2018
Interactions between genetic variants and environmental factors affect risk of esophageal adenocarcinoma and Barrett’s esophagus,"J Dong, DM Levine, MF Buas, R Zhang, L Onstad, RC Fitzgerald, ...","Clinical Gastroenterology and Hepatology 16 (10), 1598-1606. e4",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2236189885390346846,4,2018
Tumor Suppressor Genes,"C Caldas, AR Venkitaraman",Elsevier,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11845576963426680778,4,2017
The relationship between common genetic markers of breast cancer risk and chemotherapy-induced toxicity: a case-control study,"L Dorling, S Kar, K Michailidou, L Hiller, AL Vallier, S Ingle, R Hardy, ...","PloS one 11 (7), e0158984",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=852940327205132409,4,2016
Modeling Breast Cancer Intertumor and Intratumor Heterogeneity Using Xenografts,"A Bruna, OM Rueda, C Caldas","Cold Spring Harbor symposia on quantitative biology 81, 227-230",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17770420056065646086,4,2016
Breast cancer: Tamoxifen—When more might be better,"C Caldas, IF Tannock","Nature Reviews Clinical Oncology 10 (3), 125",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2801947929972323829,4,2013
PathGrid: a service-orientated architecture for microscopy image analysis,"NA Walton, JD Brenton, C Caldas, MJ Irwin, A Akram, E Gonzalez-Solares, ...","Philosophical Transactions of the Royal Society A: Mathematical, Physical …",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17523504116978944532,4,2010
The Genomic and Immune Landscapes of Lethal Metastatic Breast Cancer,"L De Mattos-Arruda, SJ Sammut, EM Ross, R Bashford-Rogers, ...","Cell reports 27 (9), 2690-2708. e10",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3556584917267958050,3,2019
"Combined quantitative measures of ER, PR, HER2, and KI67 provide more prognostic information than categorical combinations in luminal breast cancer","M Abubakar, J Figueroa, HR Ali, F Blows, J Lissowska, C Caldas, ...","Modern Pathology, 1",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6102258976459805384,3,2019
Genome-wide association study of germline variants and breast cancer-specific mortality,"M Escala-Garcia, Q Guo, T Dörk, S Canisius, R Keeman, J Dennis, ...","British journal of cancer 120 (6), 647",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18297224324567978943,3,2019
Decline in antigenicity of tumor markers by storage time using pathology sections cut from tissue microarrays,"FM Blows, HR Ali, SJ Dawson, J Le Quesne, E Provenzano, C Caldas, ...","Applied Immunohistochemistry & Molecular Morphology 24 (3), 221",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12755283823821031284,3,2016
ARTemis: Randomized trial with neoadjuvant chemotherapy for patients with early breast cancer.,"HM Earl, C Blenkinsop, L Grybowicz, AL Vallier, DA Cameron, ...","Journal of Clinical Oncology 30 (15_suppl), TPS1144-TPS1144",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12176734632113250607,3,2012
"Hereditary diffuse gastric cancer: Natural history, pathology, screening limitations, and prophylactic total gastrectomy in ","HT Lynch, C Caldas, D Wirtzfeld, C Vaccaro, W Rubinstein, S Weissman, ...","Journal of Clinical Oncology 25 (18_suppl), 4500-4500",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1899054358640762904,3,2007
A quantum leap in our knowledge of breast cancer mutations,"C Caldas, PAW Edwards","Breast Cancer Research 8 (6), 304",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11054320252409548661,3,2006
"A report from a conference jointly organised by the European Academy of Cancer Sciences and the Pontifical Academy of Sciences, The Vatican, November 16–17, 2018",European Academy of Cancer Sciences,"Molecular oncology 13 (3), 511-516",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11429561932032227591,2,2019
EN1 is a transcriptional dependency in triple-negative breast cancer associated with brain metastasis,"G Peluffo, A Subedee, NW Harper, N Kingston, B Jovanović, F Flores, ...","Cancer research, canres. 3264.2018",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3339066923215465635,2,2019
αE‐catenin is a candidate tumor suppressor for the development of E‐cadherin‐expressing lobular‐type breast cancer,"JS de Groot, MAK Ratze, M van Amersfoort, T Eisemann, EJ Vlug, ...","The Journal of pathology 245 (4), 456-467",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9146804087701824662,2,2018
Saccharomyces cerevisiae-like 1 (SEC14L1) is a prognostic factor in breast cancer associated with lymphovascular invasion,"SN Sonbul, MA Aleskandarany, S Kurozumi, C Joseph, MS Toss, ...","Modern Pathology, 1",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3262729674025922181,2,2018
The integrated genomic and immune landscapes of lethal metastatic breast cancer (MBC).,"L De Mattos-Arruda, SJ Sammut, EM Ross, R Bashford-Rogers, ...","Journal of Clinical Oncology 36 (15_suppl), 1009-1009",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9931402980690193876,2,2018
Cambridge Brain Mets Trial 1 (CamBMT1): A proof of principle study of afatinib penetration into cerebral metastases (mets) for patients (pts) undergoing neurosurgical resection …,"RD Baird, J Garcia-Corbacho, C Linossi, SS Kumar, D Smith, M Williams, ...","Journal of Clinical Oncology 35 (15_suppl), 2008-2008",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16385683053379701995,2,2017
Prognosis of oesophageal and gastro-oesophageal junctional cancer,"CJ Peters, C Caldas, RC Fitzgerald","US Patent 9,606,122",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1480850185738178472,2,2017
"Disease-free (DFS) and overall survival (OS) at 3.4 years (yrs) for neoadjuvant bevacizumab (Bev) added to docetaxel followed by fluorouracil, epirubicin and cyclophosphamide …","HM Earl, L Hiller, J Dunn, C Blenkinsop, L Grybowicz, AL Vallier, ...","Journal of Clinical Oncology 34 (15_suppl), 1014-1014",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15176260013404900214,2,2016
Abstract PD3-01: CDK7: A marker of poor prognosis and tractable therapeutic target in triple-negative breast cancer,"WM Gallagher, B Li, TN Chonghaile, Y Fan, R Klinger, AE O'Connor, ...","Cancer Research 76 (4 Supplement), PD3-01-PD3-01",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10992599523418473055,2,2016
Abstract A31: Integrative differential allelic expression analysis efficiently reveals the biology underlying risk to breast cancer,"J Xavier, R Russell, BP Almeida, N Rosli, C Rocha, S Samarajiwa, ...","Molecular Cancer Research 14 (2 Supplement), A31-A31",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8051247479771567533,2,2016
Abstract PD2-3: ARTemis: A randomised trial of bevacizumab with neo-adjuvant chemotherapy for patients with HER2-negative early breast cancer,"HM Earl, L Hiller, JA Dunn, C Blenkinsop, L Grybowicz, AL Vallier, ...","Cancer Research 75 (9 Supplement), PD2-3-PD2-3",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2614467254190209927,2,2015
Abstract PD6-5: Pooled analysis of circulating tumor cells in metastatic breast cancer: Findings from 1944 individual patients data,"FC Bidard, D Peeters, T Fehm, F Nole, R Gisbert-Criado, D Mavrudis, ...","Cancer Research 73 (24 Supplement), PD6-5-PD6-5",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1790290824094681855,2,2013
Abstract A8: The EurOPDX consortium: Sharing patient tumor-derived xenografts for collaborative multicentric preclinical trials.,"E Vinolo, E Marangoni, V Serra, F Amant, A Bertotti, AV Biankin, ...","Molecular Cancer Therapeutics 12 (11 Supplement), A8-A8",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18068102783209286666,2,2013
Neo-tAnGo science: A translational study of PAM 50 sub-typing in sequential fresh tissue samples during neoadjuvant chemotherapy.,"HM Earl, SF Chin, M Dunning, M Iddawela, O Rueda, R Russell, L Jones, ...","Journal of Clinical Oncology 31 (15_suppl), 1015-1015",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16472361665656157281,2,2013
OC-017 TRIM44: From prognosis to therapy in oesophageal adenocarcinoma and breast cancer,"CAJ Ong, NB Shannon, P Lao-Sirieix, C Ross-Innes, M O'Donovan, ...","Gut 61 (Suppl 2), A8-A8","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3524061189705334573,1649045397526892222",2,2012
A sparse regulatory network of copy-number driven expression reveals putative breast cancer oncogenes,"Y Yuan, C Curtis, C Caldas, F Markowetz",2010 IEEE International Conference on Bioinformatics and Biomedicine (BIBM …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9182662615010482731,2,2010
RET protein expression in papillary renal cell carcinoma,"R Flavin, SP Finn, TK Choueiri, O Sheils, RJ Flavin, M Guerin, DS O'Briain, ...","PLoS Biology 8 (7), e1000410",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11546343667777745033,2,2010
Deep Zoom and touch screen for tissue microarray image scoring,"C Crichton, J Davies, J Gibbons, A Tsui, J Brenton, C Caldas, L Morris",Poster at Microsoft External Research Symposium,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13666231104432455384,2,2010
NRG1 is frequently silenced by methylation in breast cancers and is a strong candidate for the 8p tumour suppressor gene,"YL Chua, Y Ito, JCM Pole, SF Chin, IO Ellis, C Caldas, MJ O'Hare, ...","Breast Cancer Research 10 (2), P11",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=846056551963198498,2,2008
Confirmation of frequent somatic deletion of the 13q12. 3 locus encompassing BRCA2 in chronic lymphocytic leukaemia.,"JA Garcia-Marco, B Navarro, C Caldas","British journal of haematology 99 (3), 708-709",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1289089653275645181,2,1997
Clonal decomposition and DNA replication states defined by scaled single-cell genome sequencing,"E Laks, A McPherson, H Zahn, D Lai, A Steif, J Brimhall, J Biele, B Wang, ...","Cell 179 (5), 1207-1221. e22",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11018136797386818716,1,2019
A key genomic subtype associated with lymphovascular invasion in invasive breast cancer,"S Kurozumi, C Joseph, S Sonbul, S Alsaeed, Y Kariri, A Aljohani, S Raafat, ...","British journal of cancer 120 (12), 1129",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3173733055746172679,1,2019
PDLIM2 is a marker of adhesion and β-catenin activity in triple-negative breast cancer,"OT Cox, SJ Edmunds, K Simon-Keller, B Li, B Moran, NE Buckley, ...","Cancer research 79 (10), 2619-2633",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8354221016425256236,1,2019
T-cell bispecific antibodies in node-positive breast cancer: novel therapeutic avenue for MHC class I loss variants,"M Messaoudene, TP Mourikis, J Michels, Y Fu, M Bonvalet, ...","Annals of Oncology 30 (6), 934-944",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9410819533391400622,1,2019
No Association Between Vitamin D Status and Risk of Barrett's Esophagus or Esophageal Adenocarcinoma: A Mendelian Randomization Study,"J Dong, P Gharahkhani, WH Chow, MD Gammon, G Liu, C Caldas, ...",Clinical Gastroenterology and Hepatology,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17622798593855757472,1,2019
Chromosome 12p amplification in triple-negative/BRCA1-mutated breast cancer associates with emergence of docetaxel resistance and carboplatin sensitivity,"J Gómez-Miragaya, A Díaz-Navarro, R Tonda, S Beltran, L Palomero, ...","Cancer Research, canres. 3835.2018",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6676968996675186200,1,2019
Biomarkers of response to CDK4/6 inhibitor (CDK4/6i) in hormone receptor (HR) positive and HER2-positive breast cancer (BC) patient-derived xenografts (PDX),"M Palafox, MT Herrera-Abreu, M Bellet, M Oliveira, A Bruna, O Rodriguez, ...","Cancer Research 78 (13 Supplement), 3596-3596",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5740813488793238931,1,2018
The EurOPDX EDIReX project: Towards a European research infrastructure on patient-derived cancer models,"E Medico, M Bentires-Alj, AV Biankin, A Bruna, AT Byrne, C Caldas, ...","Cancer Research 78 (13 Supplement), 985-985",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4524483549453363285,1,2018
Of mice and men: Patient-derived xenografts in cancer medicine,"D Hochhauser, C Caldas","Annals of Oncology 28 (10), 2330-2331",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1424620962545176921,1,2017
"What John Shirley Said About Adam: Authorship and Attribution in Cambridge, Trinity College, MS R. 3.20",M Connolly,The Dynamics of the Medieval Manuscript,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5320680610917386750,1,2017
A comparative study of endoscopic surveillance in hereditary diffuse gastric cancer according to CDH1 mutation status,"R Fitzgerald, M Tischkowitz, M Di Pietro, M O'Donovan, S Richardson, ...",Elsevier,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11860829179543870099,1,2017
Abstract P4-07-05: PARP inhibition in breast and ovarian patient-derived tumor xenografts (PDX) harboring germline BRCA1/2 mutations unveils mechanisms of primary and acquired …,"C Cruz, L Bustos, A Gris, M Palafox, M Castroviejo, A Llop, B Morancho, ...","Cancer Research 76 (4 Supplement), P4-07-05-P4-07-05",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7126604055943080149,1,2016
Basic cancer research: why it is essentiel for the future of cancer therapy,"Y Yarden, C Caldes","Bulletin du cancer 101 (9), E25-E26",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4077260686113305765,1,2014
Video Q&A: molecular profiling of breast cancer,C Caldas,"BMC medicine 11 (1), 150",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12240530575957279149,1,2013
A metadata-aware application for remote scoring and exchange of tissue microarray images,"L Morris, A Tsui, C Crichton, S Harris, PH Maccallum, WJ Howat, J Davies, ...","BMC bioinformatics 14 (1), 147",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7214996557342530441,1,2013
PWE-164 Utilizing Integrative Genomic Analysis and Proteomics to Decipher the Biology and Therapeutic Potential of Trim44 in Oesophageal Adenocarcinoma and Breast Cancer,"JC Ong, N Shannon, J Skehel, K Wang, OM Rueda, CE Walker, ...","Gut 62 (Suppl 1), A197-A197",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3155392891419544716,1,2013
Basic cancer research: why it is essential for the future of cancer therapy,C Caldas,"European Journal of Cancer 49, 2619-2620",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16134286839667185021,1,2013
Non-rigid registration of sequential DCE-MRI in the assessment of response to neoadjuvant chemotherapy in breast cancer,"T Catherwood, A Patterson, K Zaki, M Iddawela, H Earl, C Caldas, K Sayal, ...","Proc. Intl. Soc. Mag. Reson. Med.(ISMRM) 21, 3730",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4612933040138780690,1,2013
Abstract P2-10-20: A tumor DNA complexity index is an independent predictor of survival in a dataset of 1950 breast cancers; a METABRIC group study.,"HKM Vollan, OM Rueda, AL Børresen-Dale, S Aparicio, C Caldas","Cancer Research 72 (24 Supplement), P2-10-20-P2-10-20",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11701726024112729835,1,2012
C-Myb as a Prognostic Marker in Breast Cancer and Its Role in Defining Sub-Groups with Poor Overall Survival,"M Iddawela, R Ali, F Blows, P Pharoah, H Earl, C Caldas",Asia-Pacific Journal of Clinical Oncology 8,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8095606117494524538,1,2012
Automated image analysis of nuclear immunomarkers in breast cancer: data on 2064 cases tissue microarrays,"N Makretsov, S Dawson, J Mercer, E Provenzano, W Howat, L Morris, ...","VIRCHOWS ARCHIV 455, 400-401",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13695968481815406067,1,2009
Cytochrome P450 2D6 variants and their association with breast cancer survival.,"JE Abraham, M Maranian, K Driver, D Greenberg, MN Shah, HM Earl, ...","Cancer Research 69 (2 Supplement), 3089",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13422592596657661819,1,2009
Quantitative digital image analysis of estrogen receptor immunostaining as a model for morphological screening of nuclear immunomarkers,"N Makretsov, W Howart, P Pharoah, SJ Dawson, E Provenzano, F Bows, ...","VIRCHOWS ARCHIV 452, S22-S22",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13097355378748019557,1,2008
Genetic unmasking of an epigenetically silenced microRNA in human cancer,"A Lujambio, S Ropero, E Ballestar, M Fraga, C Cerrato, F Setien, ...","Cancer Research 67 (9 Supplement), LB-208-LB-208",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4070459833998577696,1,2007
"Genetic unmasking of an epigenetically silenced microRNA in human cancer cells (vol 67, pg 1424, 2007)","A Lujambic, S Ropero, E Ballestar, MF Fraga, C Cerrato, F Setien, ...","CANCER RESEARCH 67 (7), 3492-3492",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14857240504552840732,1,2007
Molecular Forecasting of Breast Cancer: Time to Move Forward With Clinical Testing,"J Brenton, A Ahmed, C Caldas","Journal of Clinical Oncology 24 (4), 722-723",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11227427969919496733,1,2006
三种食管鳞癌细胞系的染色体异常研究,李晓昀， 苏敏,"中国癌症杂志 15 (5), 446-449",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5044194323415945845,1,2005
"Amplification of a novel BRCA2-inactivating gene, EMSY in high grade ovarian carcinomas","J Irving, L Brown, T Magliocco, T Longacre, B Gilks, C Caldas, ...","LABORATORY INVESTIGATION 83 (1), 193A-193A",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12891201774349421871,1,2003
DOP-PCR based array-CGH for extensive amplicon profiling of breast cancers: A new approach for the molecular analysis of paraffin-embedded cancer tissue.,"Y Daigo, SF Chin, G Callagy, K Gorringe, G Iyer, L Bobrow, JD Brenton, ...","AMERICAN JOURNAL OF HUMAN GENETICS 69 (4), 231-231",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4720324959383001154,1,2001
Sequence and genomic structure of the Mll gene in the compact model vertebrate genome of Fugu rubripes,"MH Kim, C Caldas, S Aparicio, A Macgregor, D Cain, CW So, ...","BRITISH JOURNAL OF HAEMATOLOGY 93, 151-151",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8801792635668883047,1,1996
"HIGH PREVALENCE OF P53 MUTATIONS, PARTICULARLY INTRAGENIC MICRODELETIONS, IN RESECTABLE PANCREATIC-CARCINOMA","MS Redston, C Caldas, AB Seymour, RH Hruban, L DACOSTA, CJ Yeo, ...","Gastroenterology 106 (4), A432-A432",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11335906693738305800,1,1994
BET inhibition as a rational therapeutic strategy for invasive lobular breast cancer,"L Walsh, KE Haley, B Moran, B Mooney, F Tarrant, SF Madden, ...","Clinical Cancer Research 25 (23), 7139-7150",,0,2019
Tumor diversity and the trade-off between universal cancer tasks,"J Hausser, P Szekely, N Bar, A Zimmer, H Sheftel, C Caldas, U Alon","Nature communications 10 (1), 1-13",,0,2019
Association Between Levels of Hormones and Risk of Esophageal Adenocarcinoma and Barrett’s Esophagus,"SH Xie, R Fang, M Huang, J Dai, AP Thrift, LA Anderson, WH Chow, ...",Clinical Gastroenterology and Hepatology,,0,2019
"POSEIDON Trial Phase 1b Results: Safety, Efficacy and Circulating Tumor DNA Response of the Beta Isoform-Sparing PI3K Inhibitor Taselisib (GDC-0032) Combined with Tamoxifen in …","RD Baird, AGJ van Rossum, M Oliveira, K Beelen, M Gao, M Schrier, ...","Clinical Cancer Research 25 (22), 6598-6605",,0,2019
"ARID1A influences HDAC1/BRD4 activity, intrinsic proliferative capacity and breast cancer treatment response","J Carroll, S Nagarajan, SV Rao, J Sutton, D Cheeseman, S Dunn, ...",Springer Nature,,0,2019
PathTracer: High-sensitivity detection of differential pathway activity in tumours,"S Nygård, OC Lingjærde, C Caldas, E Hovig, AL Børresen-Dale, ...","Scientific reports 9 (1), 1-8",,0,2019
368P Genomic analysis of malaysian breast cancers unravel molecular differences from Caucasian breast cancers,"SH Teo, M Zabidi, JW Pan, PS Ng, MY Meng, N Hasan, B Sandey, CH Yip, ...","Annals of Oncology 30 (Supplement_9), mdz431. 005",,0,2019
"POSEIDON phase 1b results: safety, efficacy and ctDNA response of taselisib combined with tamoxifen in hormone receptor positive metastatic breast cancer patients.","R Baird, AG van Rossum, M Oliveira, KJ Beelen, M Gao, M Schrier, ...",American Association for Cancer Research,,0,2019
Reversing PARP inhibitor resistance by targeting the replication stress response,"MJ O'Connor, C Cruz, M Castroviejo-Bermejo, UM Polanska, GN Jones, ...","Cancer Research 79 (13 Supplement), 932-932",,0,2019
Biomarkers for inhibitors of the replication stress response proteins WEE1 and ATR in triple negative breast cancer,"V Serra, C Cruz, Z Lai, M Castroviejo-Bermejo, M Palafox, UM Polanska, ...","Cancer Research 79 (13 Supplement), 3503-3503",,0,2019
6 versus 12 months of adjuvant trastuzumab in patients with HER2 positive breast cancer (PERSEPHONE): definitive 4-year disease-free survival results of an open label …,"HM Earl, L Hiller, A Vallier, S Loi, K McAdam, L Hughes-Davis, AN Harnett, ...",Elsevier,,0,2019
Publisher Correction: Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy,"JL Caswell-Jin, K McNamara, JG Reiter, R Sun, Z Hu, Z Ma, J Ding, ...","Nature communications 10 (1), 2433",,0,2019
Chlorambucil targets BRCA1/2‐deficient tumours and counteracts PARP inhibitor resistance,"EMC Tacconi, S Badie, G De Gregoriis, T Reisländer, X Lai, M Porru, ...",EMBO molecular medicine,,0,2019
The genomic and immune landscapes of lethal metastatic breast cancer,"S Sammut, L de Matos Arruda, C Caldas",Elsevier,,0,2019
6 versus 12 months of adjuvant trastuzumab in patients with HER2 positive early breast cancer (PERSEPHONE): definitive 4-year disease-free survival results of an open-label …,"H Earl, L Hiller, AL Vallier, S Loi, K McAdam, L Hughes-Davies, ...",The Lancet Publishing Group,,0,2019
Dynamics of breast cancer relapse reveal late recurring ER-positive genomic subgroups,"O Rueda Palacio, SJ Sammut, JA Seoane, SF Chin, JL Caswell-Jin, ...",Nature Publishing Group,,0,2019
Abstract P3-06-01: Clonal evolution and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy,"JL Caswell-Jin, K McNamara, JG Reiter, R Sun, Z Hu, Z Ma, CJ Suarez, ...","Cancer Research 79 (4 Supplement), P3-06-01-P3-06-01",,0,2019
Abstract P4-01-21: Multiplexed targeted digital sequencing of circulating tumor DNA to detect minimal residual disease in early and locally advanced breast cancer,"BR McDonald, T Contente-Cuomo, SJ Sammut, B Ernst, ...","Cancer Research 79 (4 Supplement), P4-01-21-P4-01-21",,0,2019
Abstract GS3-06: Dynamics of breast cancer relapse reveal molecularly defined late recurring ER-positive subgroups: Results from the METABRIC study,"C Curtis, OM Rueda, SJ Sammut, SF Chin, JL Caswell-Jin, JA Seoane, ...","Cancer Research 79 (4 Supplement), GS3-06-GS3-06",,0,2019
Abstract P5-12-03: Genome copy number entropy as predictor of response for neoadjuvant therapy in early breast cancer,"E Alba, OM Rueda, A Lluch, J Albanell, SF Chin, JI Chacón, L Calvo, ...","Cancer Research 79 (4 Supplement), P5-12-03-P5-12-03",,0,2019
Abstract PD7-01: Bromodomain protein 3 is a novel therapeutic target in invasive lobular carcinoma,"K Haley, L Walsh, B Moran, S Das, F Tarrant, C Caldas, R Bernards, ...","Cancer Research 79 (4 Supplement), PD7-01-PD7-01",,0,2019
Abstract OT1-01-07: PIONEER-Pre-operative wIndOw study of letrozole plus PR agonist megestrol acetate versus letrozole aloNE in post-menopausal patients with ER-positive breast …,"SS Kumar, J Benson, S McIntosh, P King, G Dougall, A Kateb, AL Vallier, ...","Cancer Research 79 (4 Supplement), OT1-01-07-OT1-01-07",,0,2019
Dynamics of breast cancer relapse reveal molecularly defined late recurring ER-positive subgroups: Results from the METABRIC study,"C Curtis, OM Rueda, SJ Sammut, SF Chin, JL Caswell-Jin, JA Seoane, ...",CANCER RESEARCH 79 (4),,0,2019
Multiplexed targeted digital sequencing of circulating tumor DNA to detect minimal residual disease in early and locally advanced breast cancer,"BR McDonald, T Contente-Cuomo, SJ Sammut, B Ernst, ...",CANCER RESEARCH 79 (4),,0,2019
Fbxl17 is rearranged in breast cancer and loss of its activity leads to increased global ,"B Mason, S Flach, FR Teixeira, RM Garcia, OM Rueda, JE Abraham, ...","Cellular and Molecular Life Sciences, 1-16",,0,2019
Copy number motifs expose genome instability type and predict driver events and disease outcome in breast cancer,"AV Pladsen, G Nilsen, OM Rueda, MR Aure, Ø Borgan, K Liestøl, V Vitelli, ...","bioRxiv, 769356",,0,2019
The GATA3 X308_Splice breast cancer mutation is a hormone context-dependent oncogenic driver,"N Hruschka, M Subijana, O Graña-Castro, F Del Cano-Ochoa, LP Brunet, ...","BioRxiv, 664367",,0,2019
EZH2 is overexpressed in BRCA1-like breast tumors and predictive for sensitivity to high-dose platinum-based chemotherapy,"J Puppe, M Opdam, PC Schouten, K Jóźwiak, EH Lips, T Severson, ...","Clinical Cancer Research, clincanres. 4024.2018",,0,2019
Exploring germline variation in known cancer predisposing genes amongst CDH1-negative hereditary diffuse gastric cancer families,"ER Fewings, A Larionov, J Redman, M Goldgraben, R Hardwick, ...","EUROPEAN JOURNAL OF HUMAN GENETICS 26, 570-571",,0,2018
Bromodomain inhibitors for the treatment of invasive lobular carcinoma,"DP O'connor, L Walsh, Y Fan, F Tarrant, SF Chin, P Schouten, C Caldas, ...","Cancer Research 78 (13 Supplement), 5791-5791",,0,2018
Patient level polygenic risk scores and continuous estrogen receptor expression in breast cancer,"AH Shetty, R Ali, F Blows, C Caldas, N Inard, J Benítez, J Chang-Claude, ...","Cancer Research 78 (13 Supplement), 2211-2211",,0,2018
11 The heterogeneous genomic and immune landscapes of lethal metastatic breast cancer,"L De Mattos-Arruda, SJ Sammut, EM Ross, R Bashford-Rogers, ...","ESMO Open 3 (Suppl 2), A5-A5",,0,2018
6 Imaging tumour metabolism to guide treatment of breast cancer with drugs targeted at PI3K alpha,"S Ros, P D’Santos, D Hu, AJ Wright, RL Hesketh, AS Batra, E Mannion, ...","ESMO Open 3 (Suppl 2), A3-A3",,0,2018
PO-491 Single-cell phenotypic profiling of breast cancerpatient-derived tumour xenografts using mass cytometry,"D Georgopoulou, M Callari, A Martin, OM Rueda, W Greenwood, ...","ESMO Open 3 (Suppl 2), A214-A214",,0,2018
PO-386 Decoding the regulatory role and epiclonal dynamics of DNA methylation in 1482 breast tumours,"RN Batra, AV Tufedgzic, SF Chin, AS Batra, M Callari, SJ Sammut, ...","ESMO Open 3 (Suppl 2), A173-A173",,0,2018
Biomarkers: New Tool to Detect Subclinical Inflammation?,"N Serra, BB Bardaji, OO Millan, CC Facundo, CC Canal, II Silva, YY Arce, ...","Transplantation 102, S104",,0,2018
Integrative cluster classification to predict pathological complete response to neoadjuvant chemotherapy in early breast cancer.,"E Alba, OM Rueda, A Lluch, J Albanell, SF Chin, JI Chacon, L Calvo, ...","Journal of Clinical Oncology 36 (15_suppl), 579-579",,0,2018
Sperm associated antigen 5 (SPAG5) as a predictor and monitor for response and distant relapse risk (DRR) to endocrine (ET) and chemo-therapies (CT) in oestrogen receptor …,"TMA Abdel-Fatah, G Ball, AMC Reid, P Simpson, SR Lakhani, L Pongor, ...","Journal of Clinical Oncology 36 (15_suppl), 1066-1066",,0,2018
Dynamic genomic instability modulation by neoadjuvant therapy in early breast cancer (GEICAM/2006-03_2006-14).,"E Alba, OM Rueda, A Lluch, J Albanell, SF Chin, JI Chacon, L Calvo, ...","Journal of Clinical Oncology 36 (15_suppl), 592-592",,0,2018
Interrogating open issues in cancer precision medicine with patient-derived xenografts,A Byrne,"RADIOTHERAPY AND ONCOLOGY 127, S119-S120",,0,2018
Feasibility of metabolic imaging of hyperpolarized 13C-pyruvate in human breast cancer,"M McLean, CJ Daniels, J Grist, RF Schulte, T Lanz, A Chhabra, H Earl, ...",Springer Nature,,0,2018
Abstract P1-09-02: Bromodomain inhibitors for the treatment of invasive lobular carcinoma,"L Walsh, Y Fan, F Tarrant, SF Chin, P Schouten, C Caldas, R Bernards, ...","Cancer Research 78 (4 Supplement), P1-09-02-P1-09-02",,0,2018
PERSEPHONE: a randomised phase 3 non-inferiority trial of 6 versus 12 months (m) of adjuvant trastuzumab in patients with HER2 positive (+) early breast cancer (EBC),"H Earl, L Hiller, L Vallier, S Loi, D Howe, H Higgins, K McAdam, ...",,,0,2018
Detection of residual disease after neoadjuvant therapy in breast cancer using personalized circulating tumor DNA analysis,"BR McDonald, T Contente-Cuomo, SJ Sammut, A Odenheimer-Bergman, ...","BioRxiv, 425470",,0,2018
Bcl11a Marks Mammary Progenitor Cells and Promotes Early Cellular Changes Associated with TNBC by Recruiting Chd8,"S Pensa, KA Lazarus, K Bach, MF Santolla, M Maggiolini, J Cassidy, ...",,,0,2018
"Universal cancer tasks, evolutionary tradeoffs, and the functions of driver mutations","J Hausser, P Szekely, N Bar, A Zimmer, H Sheftel, C Caldas, U Alon","bioRxiv, 382291",,0,2018
"Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation (vol 5, 4999, 2014)","M Ghoussaini, SL Edwards, K Michailidou, S Nord, RCS Lari, K Desai, ...",Nature Communications 9,,0,2018
Erratum to: Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancer,"Z Hu, JH Mao, C Curtis, G Huang, S Gu, L Heiser, ME Lenburg, ...","Breast Cancer Research 19 (1), 17",,0,2017
High-risk individuals’ perceptions of reproductive genetic testing for CDH1 mutations,"N Hallowell, S Badger, S Richardson, C Caldas, RH Hardwick, ...","Familial cancer 16 (4), 531-535",,0,2017
"p120-catenin prevents multinucleation through control of MKLP1-dependent RhoA activity during cytokinesis (vol 7, 13874, 2016)","RAH van de Ven, JS de Groot, D Park, R van Domselaar, D de Jong, ...",NATURE COMMUNICATIONS 8,,0,2017
Corrigendum: p120-catenin prevents multinucleation through control of MKLP1-dependent RhoA activity during cytokinesis,"RAH van de Ven, JS de Groot, D Park, R van Domselaar, D de Jong, ...","Nature communications 8, 16030",,0,2017
Glutamine Transporters SLC1A5 and SLC7A5 are Key Therapeutic Targets in Luminal B Breast Cancer,"R El-Ansari, MA Aleskandarany, KW Cheng, M Diez-Rodriguez, ...","JOURNAL OF PATHOLOGY 243, S16-S16",,0,2017
295PPneumocystis jiroveci pneumonia (PCP) in patients receiving weekly chemotherapy for metastatic breast cancer,"ST Wijaya, E Harrison, M Moody, C Wilson, L Hughes-Davies, C Caldas, ...",Annals of Oncology 28 (suppl_5),,0,2017
213TiPPIONEER-Pre-operative wIndOw study of letrozole plus PR agonist megestrol acetate versus letrozole aloNE in post-menopausal patients with ER-positive breast cancer,"SS Kumar, G Dougall, AL Vallier, L Jones, W Qian, E Provenzano, ...",Annals of Oncology 28 (suppl_5),,0,2017
リキッドバイオプシー時代の到来: 血中循環腫瘍 DNA 解析の実施に向けて,"J Wan, C Massie, J Garcia-Corbacho, F Mouliere, JD Brenton, C Caldas, ...","Nature reviews. Cancer, clinical oncology 7 (3), 95-113",,0,2017
Imaging tumor metabolism to guide treatment of breast cancer with drugs targeted at PI3K alpha,"S Ros, P D'Santos, D Hu, AS Batra, AJ Wright, E Mannion, A Bruna, ...","Cancer Research 77 (13 Supplement), 2853-2853",,0,2017
Integrative analysis of molecular and drug response data from clinical samples and PDTXs to identify pharmacogenomic associations in breast cancer,"M Callari, RN Batra, AS Batra, W Greenwood, SF Chin, A Bruna, ...","Cancer Research 77 (13 Supplement), 2991-2991",,0,2017
Epigenetic modulators for the treatment of invasive lobular carcinoma breast cancer,"L Walsh, B Moran, S Das, F Tarrant, P Schouten, SF Chin, R Bernards, ...","Cancer Research 77 (13 Supplement), 4674-4674",,0,2017
Cancer Genomics,"J Brenton, C Caldas, Y Samuels",,,0,2017
Cell division cycle 25C (CDC25C) expression confers poor prognosis in invasive breast cancer,"S Ojiegbe, C Joseph, E Provenzano, C Caldas, C Nolan, AR Green, ...",,,0,2017
Loss of MED23 leads to poor prognosis in invasive breast cancer,"TA Aliyeva, C Joseph, E Provenzano, R Russell, C Caldas, S Sonbul, ...",,,0,2017
Elevated expression of STK3 mRNA and protein is associated with poor outcome in invasive breast cancer,"S Ojiegbe, C Joseph, E Provenzano, C Caldas, C Nolan, AR Green, ...",,,0,2017
Blocking both driver and escape pathways to overcome endocrine resistance,I Krop,"The Breast 32, S4",,0,2017
Lympho-Vascular Invasion (LVI) Supervised Transcriptomic Study Disclosed Clusters of Genes with Significant Prognostic Importance in Invasive Breast Carcinoma,"SN Sonbul, AR Green, OM Rueda, A Mukherjee, MA Aleskandarany, ...","JOURNAL OF PATHOLOGY 241, S8-S8",,0,2017
Central Pathology Review with Two-Stage Quality Assurance for Pathological Response After Neoadjuvant Chemotherapy in the ARTemis Trial,"E Provenzano, JS Thomas, L Hiller, J Dunn, C Blenkinsop, L Grybowicz, ...","JOURNAL OF PATHOLOGY 241, S10-S10",,0,2017
Abstract OT1-04-01: Cambridge brain mets trial 1 (CamBMT1): A proof-of-principle phase 1b/randomised phase 2 study of afatinib penetration into brain metastases for patients …,"RD Baird, N Ramenatte, C Watts, A Jonson, L Jones, H Biggs, E Harrison, ...","Cancer Research 77 (4 Supplement), OT1-04-01-OT1-04-01",,0,2017
Abstract P6-09-16: Identification of proliferation related derivers and their roles in precision medicine for breast cancers: A retrospective multidimensional comparative …,"TMA Abdel-Fatah, D Agarwal, D Zafeiris, L Pongor, B Györffy, OM Rueda, ...","Cancer Research 77 (4 Supplement), P6-09-16-P6-09-16",,0,2017
Abstract P6-11-06: Bromodomain inhibitors represent a rational therapeutic option for the treatment of invasive lobular carcinoma,"DP O'Connor, L Walsh, F Tarrant, SF Chin, P Schouten, S Linn, ...","Cancer Research 77 (4 Supplement), P6-11-06-P6-11-06",,0,2017
"Abstract OT2-01-11: Phase II of POSEIDON: A phase Ib/randomized phase II trial of tamoxifen plus taselisib or placebo in hormone receptor positive, HER2 negative, metastatic …","M Oliveira, RD Baird, AGJ van Rossum, K Beelen, J Garcia-Corbacho, ...","Cancer Research 77 (4 Supplement), OT2-01-11-OT2-01-11",,0,2017
Large scale meta-analysis identifies new genetic risk loci for esophageal adenocarcinoma (EA) and the first EA risk locus independent of Barrett’s esophagus,"P Gharahkhani, RC Fitzgerald, TL Vaughan, I Tomlinson, I Gockel, ...",Nature Genetics,,0,2017
"Identification of proliferation related derivers and their roles in precision medicine for breast cancers: A retrospective multidimensional comparative, integrated genomic …","TMA Abdel-Fatah, D Agarwal, D Zafeiris, L Pongor, B Gyoerffy, OM Rueda, ...",CANCER RESEARCH 77,,0,2017
"Phase II of POSEIDON: A phase Ib/randomized phase II trial of Tamoxifen plus Taselisib or placebo in hormone receptor positive, HER2 negative, metastatic breast cancer patients …","M Oliveira, RD Baird, A van Rossum, K Beelen, J Garcia-Corbacho, ...",CANCER RESEARCH 77,,0,2017
Cambridge brain mets trial 1 (CamBMT1): A proof-of-principle phase 1b/randomised phase 2 study of afatinib penetration into brain metastases for patients undergoing …,"RD Baird, N Ramenatte, C Watts, A Jonson, L Jones, H Biggs, E Harrison, ...",CANCER RESEARCH 77,,0,2017
"Gemcitabine added to paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy for women with early stage breast cancer (tAnGo): an open-label, randomised …","HM Earl, L Hiller, HC Howard, JA Dunn, J Young, SJ Bowden, ...","Oncology 18 (6), 755-769",,0,2017
The BRCA1ness signature is associatedsignificantly with response to PARP inhibitor treatment versus control in theI-SPY 2 randomized neoadjuvant setting,"TM Severson, DM Wolf, C Yau, J Peeters, D Wehkam, PC Schouten, ...",Breast Cancer Research (online) 2017,,0,2017
"Interrogating open issues in cancer medicine with patient-derived xenografts (vol 17, pg 254, 2017)","AT Byrne, DG Alferez, F Amant, D Annibali, J Arribas, AV Biankin, A Bruna, ...",Nature Reviews Cancer 17 (10),,0,2017
Lack of RAD51 foci formation enables the identification of PARP inhibitor sensitive breast tumors,"M Castroviejo-Bermejo, C Cruz, S Guerra, A Llop-Guevara, ...","European Journal of Cancer 69, S122-S123",,0,2016
High expression of Rsf-1 correlates with poor prognosis in breast cancer,"C Joseph, M Craze, E Provenzano, C Nolan, C Caldas, AR Green, ...","European Journal of Surgical Oncology 42 (11), S251",,0,2016
Research data supporting “Tumor-induced IL-6 reprograms host metabolism to suppress anti-tumor immunity”,"T Flint, T Janowitz, C Connell, E Roberts, A Denton, A Coll, D Jodrell, ...",University of Cambridge,,0,2016
Nostrin as a marker related to low grade and better prognosis in breast cancer,"I Ellis, A Mukherjee, S Hamarsheh, M Craze, C Joseph, E Provenzano, ...",Wiley,,0,2016
"CamBMT1: A proof-of-principle phase 1b/randomised phase 2 study of afatinib penetration into brain metastases (mets) for patients undergoing neurosurgical resection, both with …","R Baird, J Garcia-Corbacho, N Ramenatte, A Jonson, S Ahmad, DM Smith, ...","Annals of Oncology 27 (suppl_6), 408TiP",,0,2016
Nostrin as a Marker Related to Low Grade and Better Prognosis in Breast Cancer,"S Hamarsheh, M Craze, C Joseph, E Provenzano, R Russell, C Caldas, ...","JOURNAL OF PATHOLOGY 240, 20-20",,0,2016
Further Evidence to Support that Oestrogen Receptor Expression in Breast Cancer is Bimodal,"AA Muftah, MA Aleskandarany, SN Sonbul, CC Nolan, MD Rodriguez, ...","JOURNAL OF PATHOLOGY 240, 19-19",,0,2016
Exploring Molecular Portraits Defining Low Grade in Breast Cancer,"A Mukherjee, R Russell, OM Rueda, S Hamarsheh, C Caldas, ...","JOURNAL OF PATHOLOGY 240, 19-19",,0,2016
The Prognostic Significance of KRAS-Induced Actin-Interacting Protein (KRAP) Expression in Invasive Breast Cancer,"C Joseph, R Russell, M Craze, C Nolan, E Provenzano, C Caldas, ...","JOURNAL OF PATHOLOGY 240, 16-16",,0,2016
Vesicular Transporter Proteins in Invasive Breast Cancer: Clinicopathological Relevance of Synaptosomal-Associated Protein-23 (SNAP23),"SN Sonbul, A Mukherjee, MA Aleskandarany, R Russell, O Rueda, ...","JOURNAL OF PATHOLOGY 240, 15-15",,0,2016
Phosphorylation Status of MED1 Protein Results in Differential Prognosis in Breast Cancer,"M Craze, C Joseph, R Russell, OM Rueda, E Provenzano, C Caldas, ...","JOURNAL OF PATHOLOGY 240, 26-26",,0,2016
Investigating the Role of CREM Protein in Lymphovascular Invasion in Breast Cancer,"N Barus, C Joseph, M Craze, E Provenzano, R Russell, C Caldas, ...","JOURNAL OF PATHOLOGY 240, 26-26",,0,2016
Rho-GTPase Activating-protein 18 (ARHGAP18): A Biomarker Associated with Lymphovascular Invasion in Invasive Breast Cancer,"R Surridge, MA Aleskandarany, S Sonbul, A Elmouna, I Ashankyty, ...","JOURNAL OF PATHOLOGY 240, 24-24",,0,2016
Multiple Coagulation Factor Deficiency Protein-2 (MCFD2) as a Potential Prognostic Germ Cell Marker in Invasive Breast Carcinoma: a Transcriptome-Driven Study,"SN Sonbul, A Mukherjee, R Russell, OM Rueda, MA Aleskandarany, ...","JOURNAL OF PATHOLOGY 240, 21-21",,0,2016
Androgen and Estrogen Receptor Co-regulation of Human UDP-glucuronosyltransferases 2B15 and 2B17 in Breast Cancer,"DG Hu, L Selth, G Tarulli, R Meech, D Wijayakumara, A Chanawong, ...",Androgens 2016 42,,0,2016
Abstract B02: Co-clinical trial of olaparib in breast and ovarian patient-derived tumor xenografts (PDX) enables the identification of response biomarkers,"V Serra, C Cruz, M Castroviejo, S Gutiérrez, A Llop, A Bruna, B Morancho, ...","Clinical Cancer Research 22 (16 Supplement), B02-B02",,0,2016
Germline genetic variants and risk of Barrett's esophagus and esophageal adenocarcinoma: a large scale meta-analysis of genome-wide association studies,"CL Palles, I Tomlinson, L Chegwidden, P Gharahkhani, S MacGregor, ...",Lancet Oncology 17 (10),,0,2016
RATHER: High resolution molecular profiling of invasive lobular breast cancers,"SF Chin, C Caldas","European Journal of Cancer 61, S202",,0,2016
Dynamics of relapse in breast cancer,"OM Rueda, SJ Sammut, SF Chin, B Pereira, RN Batra, M Callari, ...","European Journal of Cancer 61, S200",,0,2016
Identifying changes in mutational dynamics in patients with early breast cancer undergoing neoadjuvant chemotherapy,"SJ Sammut, SF Chin, OM Rueda, SJ Dawson, M Callari, E Provenzano, ...","European Journal of Cancer 61, S197-S198",,0,2016
A computational approach to discriminate between human and mouse reads in sequencing data from Patient Derived Tumour Xenografts,"M Callari, AS Batra, RN Batra, H Clifford, W Greenwood, SJ Sammut, ...","European Journal of Cancer 61, S195",,0,2016
The somatic mutation profiles of 173 genes in over 2400 primary breast cancers,"B Pereira, SF Chin, O Rueda, H Northen, M Ross, J Peden, D Bentley, ...","European Journal of Cancer 61, S28",,0,2016
"A retrospective study of SPAG5 expression and its clinical implications in> 8,000 patients of ER positive (ER+) breast cancer (BC): Genomic, transcriptomic and protein analysis.","TMA Abdel-Fatah, D Agarwal, DX Liu, R Russell, OM Rueda, L Pongor, ...","Journal of Clinical Oncology 34 (15_suppl), 575-575",,0,2016
CALIBRATE: Intensive profiling of circulating tumour DNA (ctDNA) from patients participating in experimental therapeutics trials including mutational profiles and copy number …,"J Garcia-Corbacho, F Mouliere, H Carr, JA Morris, F Marrass, DG Gale, ...","Journal of Clinical Oncology 34 (15_suppl), 11530-11530",,0,2016
Circulating tumor cells count-based nomograms to predict survival of metastatic breast cancer patients: Results from the European pooled analysis,"FC Bidard, D Peeters, T Fehm, F Nole, R Gisbert-Criado, D Mavroudis, ...",CANCER RESEARCH 76,,0,2016
PARP1/2 inhibition in a subset of triple negative breast cancer (TNBC) patient-derived tumor xenografts (PDX) identifies predictive biomarkers of response,"V Serra, C Cruz, A Bruna, YH Ibrahim, A Vivancos, A Vivancos, P Nuciforo, ...",CANCER RESEARCH 76,,0,2016
Abstract P6-08-10: Mutational signatures impact the breast cancer transcriptome and distinguish mitotic from immune response pathways,"JWM Martens, M Smid, G Rodríguez-González, AM Sieuwerts, ...","Cancer Research 76 (4 Supplement), P6-08-10-P6-08-10",,0,2016
Abstract P5-08-17: A study of c-Jun N-terminal kinase (JNK) and c-Jun as biomarkers in early breast cancer,"C Palmieri, B Rudraraju, A Giannoudis, D Moore, J Shaw, S Chan, IO Ellis, ...","Cancer Research 76 (4 Supplement), P5-08-17-P5-08-17",,0,2016
Abstract P2-08-08: Circulating tumor cells count-based nomograms to predict survival of metastatic breast cancer patients: Results from the European pooled analysis,"FC Bidard, D Peeters, T Fehm, F Nole, R Gisbert-Criado, D Mavroudis, ...","Cancer Research 76 (4 Supplement), P2-08-08-P2-08-08",,0,2016
Abstract P4-07-04: PARP1/2 inhibition in a subset of triple negative breast cancer (TNBC) patient-derived tumor xenografts (PDX) identifies predictive biomarkers of response,"V Serra, C Cruz, A Bruna, YH Ibrahim, A Vivancos, P Nuciforo, M Bellet, ...","Cancer Research 76 (4 Supplement), P4-07-04-P4-07-04",,0,2016
Abstract A30: RATHER: High-resolution molecular profiling of invasive lobular breast cancers,"SF Chin, M Michault, I Majewski, TM Severson, T Bismeijer, L De Korning, ...","Molecular Cancer Research 14 (2 Supplement), A30-A30",,0,2016
Abstract B06: CDK7: A marker of poor prognosis and tractable therapeutic target in triple-negative breast cancer,"B Li, TN Chonghaile, Y Fan, R Klinger, AE O'Connor, E Conroy, F Tarrant, ...","Molecular Cancer Research 14 (2 Supplement), B06-B06",,0,2016
Abstract PR01: Understanding the role of BCL11A in triple-negative breast cancer,"K Lazarus, C Caldas, P Liu, WT Khaled","Molecular Cancer Research 14 (2 Supplement), PR01-PR01",,0,2016
Corrigendum: Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells.,"YS Ju, J Tubio, W Mifsud, B Fu, HR Davies, M Ramakrishna, Y Li, ...","Genome research 26 (5), 717.2",,0,2016
Retten til å søke og nyte asyl-enkelte utvalgte spørsmål,K Solheim,The University of Bergen,,0,2015
APOBEC3B mediated cytidine deamination is required for estrogen receptor action in breast cancer,"S Ali, M Periyasamy, H Patel, CF Lai, VTM Nguyen, E Nevedomskaya, ...",Elsevier,,0,2015
SOCS2 as a Marker Related to Low Grade and Tumour Morphology in Breast Cancer,"M Craze, C Joseph, R Russel, OM Rueda, E Provenzano, C Caldas, ...",The Journal of Pathology 237,,0,2015
Exploring Molecular Mechanisms Underlying Lymphovascular Invasion in Breast Cancer,"P Sonbul, A Mukherjee, R Russell, OM Rueda, M Aleskandarany, ...",The Journal of Pathology 237,,0,2015
c-Myc Function is Associated with Specific Molecular Subtypes of Breast Cancer and Confers Resistance to Endocrine Therapy but not Chemotherapy,"AR Green, MA Aleskandarany, S El-Sheikh, CC Nolan, RD Macmillan, ...",The Journal of Pathology 237,,0,2015
MED7 in Breast Cancer: Relationship to Grade and Lymphovascular Invasion,"O Macnamara, C Joseph, M Craze, EA Rakha, R Russell, OM Rueda, ...",The Journal of Pathology 237,,0,2015
Replication of Genetic Polymorphisms Reported to Be Associated with Taxane-Related Sensory Neuropathy in Patients with Early Breast Cancer Treated with Paclitaxel—Response,"Q Guo, JE Abraham, C Caldas, HM Earl, PPD Pharoah","Clinical Cancer Research 21 (13), 3094-3094",,0,2015
"Mechanistic and clinical analysis of Sperm associated antigen 5 (SPAG5) as a novel prognostic, predictive, actionable gene in Breast Cancer (BC).","TMA Abdel-Fatah, DX Liu, D Agarwal, R Russell, OM Rueda, PM Moseley, ...","Journal of Clinical Oncology 33 (15_suppl), 1040-1040",,0,2015
"Research data supporting"" Crowdsourcing the General Public for Large Scale Molecular Pathology Studies in Cancer""","C do Reis, J Francisco, S Lynn, HR Ali, D Eccles, A Hanby, E Provenzano, ...",,,0,2015
Excellent Translational Research in Oncology: a Journey Towards Better Clinical Outcomes,"A Rajan, A Berns, U Ringborg, J Celis, B Ponder, C Caldas, D Livingston, ...",ASSESSING TRANSLATIONAL RESEARCH EXCELLENCE IN EUROPEAN COMPREHENSIVE CANCER …,,0,2015
Biomarker-driven approach in cancer therapy,"RD Baird, C Caldas","Medicographia 37, 287-295",,0,2015
Abstract PR06: Lymphocyte invasion of basal breast tumors is associated with wild-type p53,"DA Quigley, C Vaske, L Silwa-Pandit, R Dannenfelser, A Langerød, ...","Cancer Research 75 (1 Supplement), PR06-PR06",,0,2015
160 Identification of fusion genes through kinome-centered RNA sequencing in different types of solid tumors,"L Mittempergher, C Sun, FH Groenendijk, AJ Bosma, SM Willems, ...","European Journal of Cancer 50, 54",,0,2014
Rare genetic variation association with neurotoxicity and infection in breast cancer patients enrolled in PG-SNPS,"A Pirie, J Abraham, K Michailidou, J Tyrer, L Dorling, J Dennis, H Earl, ...","Cancer Research 74 (19 Supplement), 5545-5545",,0,2014
Assessing the prognostic significance of matrix metalloproteinases 14 & 15 in primary breast cancer,"T Chadwick, R Russell, O Rueda, SF Chin, B Liu, M Craze, E Provenzano, ...","VIRCHOWS ARCHIV 465, S18-S18",,0,2014
Links between pathology and transcriptomes in breast cancer: Exploring the METABRIC cohort,"A Mukherjee, E Provenzano, SF Chin, R Russell, OM Rueda, B Liu, ...","VIRCHOWS ARCHIV 465, S17-S18",,0,2014
"Association between CD8+ T-cell infiltration and breast cancer survival in 12,439 patients","E Rakha, HR Ali, E Provenzano, S Dawson, FM Blows, B Liu, M Shah, ...",Oxford University Press 25 (8),,0,2014
935 The Timing of Oncogenic Events in the Evolution of the Oesophageal Adenocarcinoma Genome and Implications for Clinical Diagnostics,"JM Weaver, C Ross-Innes, NB Shannon, A Lynch, T Forshew, M Barbera, ...","Gastroenterology 146 (5), S-161",,0,2014
22p* development of a brca1-like signature in triple negative breast cancers within the rather (rational therapy for breast cancer) consortium.,"IM Simon, J Peeters, T Severson, I Majewski, A Bosma, C Caldas, S Chin, ...",Annals of oncology: official journal of the European Society for Medical …,,0,2014
Genetic drivers of angiosarcoma discovered,S Bagcchi,"The Lancet Oncology 15 (6), e199",,0,2014
Vignette for Fletcher2013b: master regulators of FGFR2 signalling and breast cancer risk.,"MAA Castro, MNC Fletcher, X Wang, I De Santiago, M O’Reilly, SF Chin, ...",,,0,2014
The androgen receptor restricts estrogen receptor Alpha DNA binding in breast cancer cells,"TE Hickey, JL Robinson, NL Moore, R Russell, L Selth, O Rueda, ...",Endocrine Society,,0,2014
Discovery of distinct sub-groups of ER positive breast cancers by DNA repair expression profiling: Implications for patient stratification and personalization of therapy,"S Madhusudan, TMA Abdel-Fatah, R Russell, P Moseley, D Agarwal, ...",CANCER RESEARCH 73,,0,2013
Abstract P6-04-02: Defining clinically relevant molecular subtypes in lobular breast cancer within the RATHER consortium,"S Linn, I Majewski, M Michaut, J Peeters, P Schouten, L de Koning, B He, ...","Cancer Research 73 (24 Supplement), P6-04-02-P6-04-02",,0,2013
Abstract P3-04-01: Discovery of distinct sub-groups of ER positive breast cancers by DNA repair expression profiling: Implications for patient stratification and …,"S Madhusudan, TMA Abdel-Fatah, R Russell, P Moseley, D Agarwal, ...","Cancer Research 73 (24 Supplement), P3-04-01-P3-04-01",,0,2013
Vignette for Fletcher2013a: gene expression data from breast cancer cells after FGFR2 signalling.,"MAA Castro, MNC Fletcher, X Wang, I de Santiago, M O’Reilly, SF Chin, ...",,,0,2013
Abstract B020: A copy number and expression based classifier for breast cancer tumors,"OM Rueda, RH Ali, C Curtis, SF Chin, A Bruna, R Russell, B Pereira, ...","Molecular Cancer Research 11 (10 Supplement), B020-B020",,0,2013
Abstract B017: A targeted sequencing approach to characterize the mutational profiles of 178 genes in 2600 primary breast tumors,"B Pereira, SF Chin, OM Rueda, M Osborne, H Northern, J Peden, ...","Molecular Cancer Research 11 (10 Supplement), B017-B017",,0,2013
Post-Genomic and Post-Transcriptional Mechanisms in Breast Cancer,"J Le Quesne, A Modelska, J Beaton, J Warren, P Pharoah, C Caldas",The Journal of Pathology 231,,0,2013
Astronomy-based image processing for quantification of breast tumour histopathology,"H Ali, A Dariush, M Irwin, E Provenzano, F Blows, P Pharoah, N Walton, ...","VIRCHOWS ARCHIV 463 (2), 257-258",,0,2013
OC-066 The Cancer Research UK (Cruk) Funded ICGC Oesophageal Adenocarcinoma Project: MRC Research Centre and Cruk Cambridge Research Institute,"JMJ Weaver, N Shannon, C Ross-Innes, A Lynch, T Forshew, M Barbera, ...","Gut 62 (Suppl 1), A29-A29",,0,2013
"Evaluation of flap endonuclease-1 (FEN1) as a prognostic, predictive, and therapeutic target in breast (BC) and ovarian cancer (OVC).","TMA Abdel-Fatah, R Russell, DJ Maloney, V Mohan, D Dorjsuren, ...","Journal of Clinical Oncology 31 (15_suppl), 1016-1016",,0,2013
"microRNA mimics: siRNA lessons apply. miRNA mimics exhibit a significant off-target effect that is cell-line, length and dose dependent.","MA Goldgraben, A Git, O Rueda, C Caldas",CANCER RESEARCH 73 (8),,0,2013
CEBPD (C/EBPδ) acts as a tumor suppressor in hormone receptor positive breast cancer cells and may serve as biomarker to predict the need for adjuvant therapy.,"DY Mendoza-Villanueva, S Kim, HR Ali, S Sharan, TR Sarkar, C Caldas, ...","Cancer Research 73 (8 Supplement), 3464-3464",,0,2013
"Abstract LB-243: microRNA mimics: siRNA lessons apply. miRNA mimics exhibit a significant off-target effect that is cell-line, length and dose dependent.","MA Goldgraben, A Git, O Rueda, C Caldas","Cancer Research 73 (8 Supplement), LB-243-LB-243",,0,2013
Development of comprehensive molecular portraits of lobular breast cancer within the RATHER (Rational Therapy for Breast Cancer) Consortium.,"JK Peeters, I Majewski, L de Koning, Y Fan, F Tarrant, D O'Connor, ...","Cancer Research 73 (8 Supplement), 1218-1218",,0,2013
Abstract SY30-03: Monitoring tumor evolution by clonal tracking in ctDNA.,C Caldas,"Cancer Research 73 (8 Supplement), SY30-03-SY30-03",,0,2013
BRCA1-like signature in triple negative breast cancers within the RATHER (Rational Therapy for Breast Cancer) Consortium.,"T Severson, J Peeters, I Majewski, A Bosma, SF Chin, C Caldas, I Simon, ...","Cancer Research 73 (8 Supplement), 4022-4022",,0,2013
Genome Medicine,"P Shen, W Wang, AK Chi, Y Fan, RW Davis, C Scharfe","Genome 5, 50",,0,2013
Znaczenie klonalnej ewolucji genomu dla medycyny nowotworów,"S Aparicio, C Caldas","N Engl J Med 368, 842-851",,0,2013
Finding Common Regions of Alteration in Copy Number Data,"OM Rueda, R Diaz-Uriarte, C Caldas","Array Comparative Genomic Hybridization, 339-353",,0,2013
Abstract P3-08-05: Title: Copy number variation and risk of chemotherapy-related infection.,"JE Abraham, OM Rueda, SF Chin, Q Guo, P Harrington, HM Earl, ...","Cancer Research 72 (24 Supplement), P3-08-05-P3-08-05",,0,2012
Abstract OT3-3-09: ARTemis trial-randomised trial with neo-adjuvant chemotherapy for patients with early breast cancer,"HM Earl, C Blenkinsop, L Grybowicz, AL Vallier, DA Cameron, ...","Cancer Research 72 (24 Supplement), OT3-3-09-OT3-3-09",,0,2012
Biomarkers,"S Dawson, D Tsui, M Murtaza, H Biggs, S Chin, D Gale, T Forshew, ...",Annals of Oncology 23 (suppl_9),,0,2012
MONITORING OF METASTATIC BREAST CANCER USING CIRCULATING TUMOUR DNA: A COMPARISON WITH CIRCULATING TUMOUR CELLS,"S Dawson, D Tsui, M Murtaza, H Biggs, S Chin, D Gale, T Forshew, ...","ANNALS OF ONCOLOGY 23, 74-74",,0,2012
"Astronomical Algorithms for Automated Analysis of Nuclear, Cytoplasmic and Membranous Immunohistochemical Stains","H Ali, M Irwin, L Morris, S Dawson, F Blows, E Provenzano, ...",The Journal of Pathology 228,,0,2012
INTEGRATIVE ANALYSIS OF COPY NUMBER AND GENE EXPRESSION USING FFPE CORE BIOPSY TISSUE: FEASIBILITY STUDY,"M Iddawela, O Rueda, H Earl, C Caldas",Asia-pacific Journal of Clinical Oncology 8,,0,2012
OC-017 TRIM44,"CA Ong, N Shannon, P Lao-Sirieix, C Ross-Innes, M O'Donovan, ...",Gut 61 (Suppl_2),,0,2012
PWE-020 Using microarray data to elucidate the molecular phenotype of a novel oncogene and identify a therapeutic strategy,"CAJ Ong, NB Shannon, OM Rueda, R Hardwick, C Caldas, RC Fitzgerald","Gut 61 (Suppl 2), A305-A305",,0,2012
TRIM44: From Prognosis to Therapy in Esophageal Adenocarcinoma and Breast Cancer,"CAJ Ong, N Shannon, P Lao-Sirieix, C Ross-Innes, M O'Donovan, ...","GASTROENTEROLOGY 142 (5), S60-S60",,0,2012
The RIF1-PKD1L1 fusion: pointing to a novel pathway in breast cancer?,"K Bird, KD Howarth, RN Sandford, OM Rueda, C Caldas, PAW Edwards","CELLULAR ONCOLOGY 35, S16-S16",,0,2012
Mapping fusion genes in breast cancer by paired-end sequencing,"K Howarth, I Schulte, EM Batty, JCM Pole, JMJ Weaver, SL Cooke, C Ng, ...","CELLULAR ONCOLOGY 35, S44-S45",,0,2012
Chromosome breaks in breast cancer: neuregulin 1 as a recurrent target,"CVS Pike, E Batty, K Howe, O Rueda, C Caldas, K Kirschner, M Narita, ...","CELLULAR ONCOLOGY 35, S18-S19",,0,2012
254 TRIM44: From Prognosis to Therapy in Esophageal Adenocarcinoma and Breast Cancer,"CA Johnny Ong, N Shannon, P Lao-Sirieix, C Ross-Innes, M ODonovan, ...","Gastroenterology-Orlando 142 (1), S",,0,2012
"Abstract C51: Molecular markers, prognosis, and efficacy of adjuvant anthracyclines in breast cancer.","AMG Ali, E Provenzano, J Abraham, K Driver, JMS Bartlett, A Munro, ...","Molecular Cancer Therapeutics 10 (11 Supplement), C51-C51",,0,2011
Prognosis by breast cancer subtypes in patients treated with adjuvant chemotherapy in a clinical trial.,"AMG Ali, E Provenzano, J Abraham, JM Bartlett, CJ Poole, L Hiller, ...","Journal of Clinical Oncology 29 (27_suppl), 12-12",,0,2011
Subcellular Localisation of Dicer Expression Correlates with Survival and Tumour Subtype in ER-Positive Breast Cancer,"J Le Quesne, J Warren, W Howat, F Blows, P Pharoah, C Caldas",The Journal of Pathology 224,,0,2011
Novel prognostic targets identified using integrated analysis of copy number and expression data in esophageal adenocarcinoma,"XY Goh, MA Alvi, JRE Rees, SF Chin, JMJ Weaver, C Caldas, ...","Cancer Research 71 (8 Supplement), 2256-2256",,0,2011
Novel prognostic targets identified using integrated analysis of copy number and expression data in oesophageal adenocarcinoma,"XY Goh, MA Alvi, J Rees, SF Chin, J Weaver, C Caldas, R Fitzgerald","Gut 60 (Suppl 1), A174-A174",,0,2011
The China Tax Guide,"CD Ellis, A Scott, S Woollard",Springer-Verlag Berlin Heidelberg,,0,2011
PS1-022. The InterferonScape: An insight into the Integrative Systems Biology of Interferon Stimulated Genes,"S Samarajiwa, A Lynch, I Spiteri, ML Smith, C Caldas, M Narita, S Tavaré","Cytokine 1 (56), 22",,0,2011
Frequent somatic deletion of the 13q12. 3 locus encompassing,"JA Garcia-Marco, C Caldas, CM Price, LM Wiedemann, A Ashworth, ...",,,0,2011
Prognostic gene network modules in breast cancer hold promise,"AE Teschendorff, Y Jiao, C Caldas","Breast Cancer Research 12 (6), 317",,0,2010
A model to predict survival in oesophageal and junctional adenocarcinoma incorporating both clinical and molecular features: C02,"C Peters, CAJ Ong, J Rees, J Hardwick, S Vowler, C Zhang, V Save, ...",British Journal of Surgery 97,,0,2010
EAST OF ENGLAND BREAST CANCER SURVIVAL CLOSE TO BEST IN EUROPE,"GC Wishart, C Caldas, CH Brown, DC Greenberg","EJC SUPPLEMENTS 8 (6), 19-20",,0,2010
Candidate Molecular Markers as Correlates of the Basal Phenotype in Breast Cancer,"B Baker, G Ball, E Rakha, D Powe, C Caldas, I Ellis, A Green",The Journal of Pathology 222,,0,2010
A model to predict survival in oesophageal and junctional adenocarcinoma incorporating both clinical and molecular features: 1D 92955,"J Peters, J Rees, R Hardwick, J Hardwick, S Vowler, C Ong, C Zhang, ...",Diseases of the Esophagus 23,,0,2010
The proteins FABP7 and OATP2 are associated with the basal phenotype and patient outcome in human breast cancer,"A Green, H Zhang, E Rakha, G Ball, I Spiteri, M Aleskandarany, E Paish, ...",Springer US,,0,2010
Could side population cells be an indicator of progression to hormone nonresponsive breast cancer,"KM Britton, IJ Harvey, K Stemke-Hale, TWJ Lennard, AP Meeson","Breast Cancer Research 12 (1), P30",,0,2010
Chromosomal aberrations reveal novel genes with prognostic significance in esophageal adenocarcinoma,"XYC Goh, JRE Rees, SF Chin, S Newman, M O'Donovan, B YIstra, ...","Cancer Research 70 (8 Supplement), 1189-1189",,0,2010
Abstract A7: Combined copy number and expression analysis of formalin fixed-paraffin embedded (FFPE) tumours,"M Iddawela, O Rueda, Y Wang, M Faham, M El-Sheemy, G Cowley, ...","Clinical Cancer Research 16 (7 Supplement), A7-A7",,0,2010
OC-060 A clinically applicable three gene signature is independently highly prognostic in oesophageal and junctional adenocarcinoma,"CJ Peters, JRE Rees, JS Hardwick, SL Vowler, CJ Ong, C Zhang, V Save, ...","Gut 59 (Suppl 1), A24-A25",,0,2010
Muziekinstrumenten,"PF Peters, KT Bijsterveld","Kunst en Wetenschap 19 (3), 9-10",,0,2010
O-69 Predicting the probability of outcome in breast cancer–A comparison of different machine learning methods,"GC Wishart, H Campbell, EM Azzato, DC Greenberg, J Rashbass, ...","EJC SUPPLEMENTS 8, 1-36",,0,2010
Research article PREDICT: a new UK progn ostic model that predicts survival following surgery for invasive breast cancer,"GC Wishart, EM Azzato, DC Greenberg, J Rashbass, O Kearins, ...",,,0,2010
East of England Breast Cancer Survival Close to Best in Europe.,G Wishart,"Cancer Research 69 (24 Supplement), 2069-2069",,0,2009
Adjuvant UK: A UK Prognostic Model for Early Breast Cancer That Includes Mode of Detection.,"G Wishart, E Azzato, P Pharoah, D Greenberg, J Rashbass, O Kearins, ...","Cancer Research 69 (24 Supplement), 4033-4033",,0,2009
Evaluation of chromatin modifying enzymes and modified histones in breast cancer,"N Makretsov, W Howat, S Dawson, L Morris, J Lequesne, F Blows, ...","VIRCHOWS ARCHIV 455, 38-38",,0,2009
Fusion genes caused by chromosome rearrangement in breast cancer cell lines,"P Edwards, J Pole, E Batty, K Howarth, S Newman, J Beavis, I Schulte, ...","CHROMOSOME RESEARCH 17, 97-97",,0,2009
Chromosome translocations and fusion genes in breast cancer.,"KD Howarth, EM Batty, JC Beavis, KA Blood, S Newman, B Ng, JC Pole, ...","Cancer Research 69 (2 Supplement), 2021",,0,2009
A metadata approach for clinical data management in translational genomics studies in breast cancer,"JDBIP Charles, C Caldas",,,0,2009
"Astronomical Data Analysis Software and Systems XVIII ASP Conference Series, Vol. 411,© 2009 D. Bohlender, D. Durand and P. Dowler, eds. A Case Study in Modernizing Software …","A Alexov, JC Good, IR Khan",Astronomical Data Analysis Software and Systems XVIII: Proceedings of a …,,0,2009
Using LNA-ISH to detect miRNAs in archival breast tumour tissue,"J Le Quesne, N Makretsov, C Caldas",The Journal of Pathology 216,,0,2008
FABP7 Expression Predicts Better Outcome in Basal-Like Breast Cancer,"H Zhang, E Rakha, G Ball, E Paish, C Caldas, I Ellis, A Green",The Journal of Pathology 216,,0,2008
Proliferation markers and survival in early breast cancer,"R Stuart-Harris, C Caldas, S Pinder, P Pharoah",Churchill Livingstone,,0,2008
Statnote 13: a more complex analysis of variance incorporating a'repeated measures' factor,"A Hilton, RA Armstrong",,,0,2008
O-110 The challenges of using radiological ‘tumour response’as an endpoint in Neo-tAnGo: a national neo-adjuvant chemotherapy breast cancer trial,"L Hiller, N Fenwick, AL Vallier, JA Dunn, S Hilborne, L Jones, J Abraham, ...","EJC Supplements 5 (3), 33-34",,0,2007
In vivo evidence for epithelial to mesenchymal transition (EMT) in oesophageal adenocarcinoma with associated alteration in TGF-β signalling at a chromosomal level,"J Rees, SF Chin, J Marioni, B Ylstra, V Save, C Caldas, R Hardwick, ...",British Journal of Surgery 94 (8),,0,2007
Microenvironment: A disturbed background,N McCarthy,"Nature Reviews Cancer 7 (8), 566",,0,2007
Array CGH detected genomic aberrations in oesophagogastric cancer identify potential diagnostic and therapeutic targets,"J Rees, SF Chin, J Marioni, C Caldas, V Save, B Ylstra, D Alderson, ...","Cancer Research 67 (9 Supplement), 2937-2937",,0,2007
Inactivation of the second allele in patients with hereditary diffuse gastric cancer harbouring germline E-cadherin mutations,"M Barber, S Hyland, N Grehan, C Caldas, R Fitzgerald","Cancer Research 67 (9 Supplement), 1145-1145",,0,2007
Ablation of p300 induces an epithelial to mesenchymal transition in the colorectal cancer cell line HCT116: P15,"D Krubasik, N Iyer, W English, C Caldas, G Murphy",International Journal of Experimental Pathology 88 (2),,0,2007
226 NOVEL GENOMIC ABERRATIONS IN OESOPHAGOGASTRIC CANCER,"JR Rees, S Chin, JC Marioni, C Caldas, V Save, B Ylstra, D Alderdson, ...",Gut 56,,0,2007
Regulation of p53 tetramerization and nuclear export by ARC,"SYF Roger, YJ Nam, MJ Ostreicher, MD Metzl, RS Whelan, CF Peng, ...","Apoptosis 5, 7",,0,2007
PLoS Computational Biology,"AE Teschendorff, M Journee, PA Absil, R Sepulchre, C Caldas",Public Library Science,,0,2007
Regulation of p53 tetramerization and nuclear export by ARC,"R Foo, YJ Nam, MJ Ostreicher, M Metzl, R Whelan, C Peng, A Ashton, ...","Circulation 114 (suppl_18), II_35-II_35",,0,2006
"Loss of the extracellular matrix protein TGFBI induces clinical paclitaxel resistance, mitotic spindle abnormalities and centrosome amplification","A Ahmed, A Mills, C Blenkiron, C Massie, M Vias, N Gopalakrishna, ...",Bjog: An International Journal of Obstetrics and Gynaecology 113 (7),,0,2006
Somatic mutation as a possible'Second hit'in hereditary diffuse gastric cancer patients with E-cadherin germ-line mutations,"M Barber, S Hyland, N Grehan, C Bordin, C Caldas, R Fitzgerald","GASTROENTEROLOGY 130 (4), A638-A638",,0,2006
In reply [3],"JD Brenton, A Ahmed, C Caldas",Journal of Clinical Oncology 24 (4),,0,2006
Genomics and predicting drug sensitivity,C Caldas,"BBA-Reviews on Cancer 2 (1766), 167",,0,2006
"Comparative genomic hybridization of esophageal adenocarinoma and squamous cell carcinoma cell lines. Diseases of the esophagus 2006 (vol 19, pg 10, 2006","M Su, SF Chin, XY Li, P Edwards, C Caldas, RC Fitzgerald","DISEASES OF THE ESOPHAGUS 19 (2), 135-135",,0,2006
11th European Forum on Quality Improvement in Health Care,"CTOT On, N Handbook","Occup Environ Med 63 (1), 44",,0,2006
Expression profiling of chromatin remodelling genes in bladder and renal cancers,"A Veerakumarasivam, H Ozdag, A Terschendorff, S Batley, I Mills, D Neal, ...","BRITISH JOURNAL OF CANCER 91, S57-S57",,0,2004
Gastric Cancer—Keeping It in the Family,"N Gopalakrishna Iyer, C Caldas","Cancer Reviews: Asia-Pacific 2 (01), 69-79",,0,2004
PMCID: PMC139241.,"DK LG, MJ Nowaczyk, K Inoue, JR Lupski, L Wagner, CM Shenmen, ...","Biol Chem 279 (7), 5846-51",,0,2004
Germline E-cadherin mutations in hereditary diffuse,"SG Seruca, C Caldas, D Huntsman, SN Gilpin, D Gilchrist, R Hughes, ...","J Med Genet 41, 508-517",,0,2004
Identification of CDH1 germline mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probands. Human Molecular Genetics 12: 575-582.,"G Suriano, C Oliveira, P Ferreira, JC Machado, MC Bordin, O De Wever, ...",,,0,2003
Genetic predisposition to gastric and oesophageal cancer,C Caldas,Annals of Oncology 13,,0,2002
E-cadherin germline mutations and risk of gastric cancer-Reply,"P Pharoah, C Caldas, D Huntsman, P Guilford","GASTROENTEROLOGY 123 (4), 1406-1407",,0,2002
Profile of oncogene amplification in breast cancer using array based comparative genomic hybridisation,"G Callagy, Y Daigo, SF Chin, C Caldas","JOURNAL OF PATHOLOGY 198, 3A-3A",,0,2002
"Author and Subject Index Vol. 20, No. 1, 2002","RC Fitzgerald, C Caldas, A Reinacher-Schick, W Schmiegel, ...","Digestive Diseases 20 (1), 106-106",,0,2002
Prevention and progress in managment of gastrointestinal cancers,P Malfertheiner,"DIGESTIVE DISEASES 20 (1), 4-4",,0,2002
Tumour tissue microarrays: A technology for the molecular classification of breast cancer,"GM Callagy, Y Daigo, LG Bobrow, PD Pharoah, C Caldas","LABORATORY INVESTIGATION 82 (1), 30A-30A",,0,2002
Early gastric cancers and in-situ signet ring carcinomas: Pre-symptomatic lesions from prophylactic gastrectomies performed on genetically susceptible individuals,"DG Huntsman, F Carneiro, TC Smyrk, DA Owen, P Guilford, TE Muir, ...","LABORATORY INVESTIGATION 82 (1), 130A-130A",,0,2002
"Author Index Vol. 20, 2002","PET Isaacs, MJG Farthing, R Lambert, JF Rey, A Sommerville, G Livadas, ...","Digestive Diseases 20 (3-4), 294-294",,0,2002
Helicobacter pylori Virulence and Interleukin-1 Polymorphisms have a Synergistic Effect in Increasing the Risk for Chronic Atrophic Gastritis and Gastric Carcinoma,"C Figueiredo, JC Machado, R Seruca, C Caldas, S Sousa, R Carvalho, ...","Gut 49 (4), A13-A13",,0,2001
Molecular profiling of breast cancer using tumour tissue microarrays,"G Callagy, E Cattaneo, Y Daigo, L Happerfield, L Bobrow, P Pharoah, ...","JOURNAL OF PATHOLOGY 195, 25A-25A",,0,2001
11th European Forum on Quality Improvement in Health Care,"KG Monaghan, R Maung, R Seruca, CE Jackson, C Caldas, M Vekemans, ...","N Engl J Med 344, 1904-9",,0,2001
Interleukin-1 gene cluster polymorphisms associated with increased risk of intestinal-type gastric carcinoma.,"JC Machado, S Sousa, R Carvalho, C Oliveira, A Amorim, R Seruca, ...","LABORATORY INVESTIGATION 81 (1), 91A-91A",,0,2001
E-cadherin germline mutations in families with diffuse gastric cancer,"C Oliveira, JC Machado, R Carvalho, F Cameiro, R Seruca, C Caldas","LABORATORY INVESTIGATION 81 (1), 93A-93A",,0,2001
MOLECULAR GENETICS OF HEREDITARY GASTRIC CANCER,"JG Park, HK Yang, WH Kim, C Caldas, J Yokota, PJ Guilford",Journal of the National Cancer Institute 92 (21),,0,2000
"Gene structure and expression-Expression and protein-binding studies of the EEN gene family, new interacting partners for dynamin, synaptojanin and huntingtin proteins","CW So, MH Sham, SL Chew, N Cheung, CKC So, SK Chung, C Caldas, ...","Biochemical Journal 348 (2), 447-458",,0,2000
Pattern of gene expression and loss of heterozygosity at chromosome band 13q12 in chronic lymphocytic leukemia.,"JA Garcia-Marco, I Layunta, MJ Busto, C Pastor, C Caldas, MN Fernandez","BLOOD 94 (10), 490A-490A",,0,1999
Mismatch repair deficiency in human breast cancer cell lines.,"KL Gorringe, C Caldas","BRITISH JOURNAL OF CANCER 80, 26-26",,0,1999
"Guarner, L. 82 Gullo, L. 79,127 Gum Jr., JR 51 Gunderson, LL 221,291","P Borst, A Bosma, WAP Breeman, MW BOchler, U Buell, ...","Annals of Oncology 10 (4), S317-S318",,0,1999
"Guarner, L. 82 Gullo, L. 79, 127 Gum Jr., JR 51","LL Gunderson, P Borst, A Bosma, WAP Breeman, U Buell, ...","Annals of Oncology 10 (4), S317-S318",,0,1999
BRCA2 and p53 deletions in chronic lymphocytic leukemia (CLL).,"B Navarro, SF Chin, C Caldas, D Catovsky, JA Garcia-Marco","BLOOD 92 (10), 226A-226A",,0,1998
The role of FeS and (NH {sub 4}){sub 2} CO {sub 3} additives on the pressed type Fe electrode,"CA Caldas, MC Lopes, IA Carlos",,,0,1998
Analysis of gene deletions in CLL patients with 13q14 translocations.,"JA GarciaMarco, B Navarro, AC Gardiner, D Oscier, C Caldas, D Catovsky","BLOOD 90 (10), 2239-2239",,0,1997
"Identification of EEN, a novel gene that fuses to HRX in at (1 1; 1 9)(q23; p 1 3) in acute leukemia","CW So, C Caldas, A Chen, SJ Chen, QH Huang, LJ Gu, MH Sham, ...",CSHL Meeting on Cancer & Oncogene,,0,1997
Sequence and genomic structure of the MLL gene in the compact model vertebrate genome of Fugu rubripes.,"C Caldas, MH Kim, S Aparicio, LM Wiedemann","BLOOD 86 (10), 2891-2891",,0,1995
MUTATIONS OF APC AND K-RAS GENES IN COLITIS-ASSOCIATED NEOPLASIA,"MS REDSTON, N PAPADOPOULOUS, SM POWELL, C CALDAS, ...","GASTROENTEROLOGY 106 (4), A432-A432",,0,1994
GENETIC CHANGES IN COLITIS-ASSOCIATED NEOPLASIA,"MS REDSTON, A SEYMOUR, C CALDAS, S KORNACKIE, ...","LABORATORY INVESTIGATION 70 (1), A66-A66",,0,1994
Molecular genetics of pancreatic adenocarcinoma,"C Caldas, MS Redston, SA Hahn, AB Seymour, RH Hruban, CJ Yeo, ...","International Journal of Pancreatology 16 (2-3), 192-193",,0,1994
Proposal of a Modified (FIG0 1985) Classification of Stages I and II Cancer of the Uterine Cervix Marijan IlijaS Incomplete Pregnancies and Ovarian Cancer Risk Eva Negri …,"G De Palo, M Zambetti, S Pilotti, L Rottoli, G Spatti, R Fontanelli, ...","Gynecologic Oncology 47, 134",,0,1992
Comment and Reviews,CD Darlington,"Heredity 7 (1), 140",,0,1953
Biology of the cervix uteri.,S SOS,"Magyar noorvosok lapja 13 (6), 204-210",,0,1950
Effects of common germline genetic variation in cell cycle control genes on breast cancer survival: results fr om a population-based cohort.,"EM Azzato, KE Driver, F Lesueur, M Shah, D Greenberg, DF Easton, ...",,,0,0
PMC3627499.,"G Del Giudice, D Palli, M Plebani, H Boeing, HB Bueno-de-Mesquita, ...",,,0,0
PhD Studentship–Clonal and cell state heterogeneity in breast cancer xenografts (Fixed Term),"SA Board, S Balasubramanian, G Biffi, S Bohndiek, J Brenton, K Brindle, ...",,,0,0
PMC2869352.,"HF LA, B Gilks, T Nielsen, M Schulzer, S Chia, J Ragaz, A Cahn, L Linger, ...",,,0,0
SOX4-SMAD3 interaction drives TGF-β mediated oncogenesis,"SJ Vervoort, AR Lourenco, AT Vidacovic, C Frederiks, R Russell, ...","Transcriptional networks controlling breast cancer metastasis, 111",,0,0
BEX2 Is Overexpressed in a Subset of Primary Breast Cancers and Mediates Nerve Growth Factor/Nuclear Factor-KB Inhibition of Apoptosis in Breast Cancer Cell Lines,"A Naderi, AE Teschendorff, J Beigel, M Cariati, IO Ellis, JD Brenton, ...",,,0,0
PhD Studentship–Genomic and functional analysis of mutational processes in high grade serous ovarian carcinoma,"S Balasubramanian, S Bohndiek, J Brenton, K Brindle, C Caldas, J Carroll, ...",,,0,0
"Supplemental Data Imprinted Chromatin around DIRAS3 Regulates Alternative Splicing of GNG12-AS1, a Long Noncoding RNA","M Niemczyk, Y Ito, J Huddleston, A Git, S Abu-Amero, C Caldas, ...",,,0,0
Perspectives in Cancer Research,"M Satoh, N Nishimura, JS Suzuki, H SonÃ, Y Aoki, C Tohyama, ...",,,0,0
Homocopolymer Tracts in DNA Microdeletions1,"MS Redston, C Caldas, AB Seymour, RH Hruban, L da Costa, CJ Yeo, ...",,,0,0
SUPPLEMENTARY NOTES,"C Blenkiron, LD Goldstein, NP Thorne, I Spiteri, SF Chin, MJ Dunning, ...",,,0,0
Positions Available,MA Cohen,,,0,0
Senior Associate Editor,"AL Børresen-Dale, J Moreira, R Aebersold, K Alitalo, G Almouzni, ...",,,0,0
VGLL1 expression in triple negative breast cancer,"J Carr, W Hale, E Rakha, G Ball, S Watts, E Paish, C Caldas, I Ellis, ...",The Journal of Pathology 219,,0,0
STAC2 expression predicts worse outcome in basal-like breast cancer,"W Hale, J Carr, E Rakha, G Ball, S Watts, E Paish, C Caldas, I Ellis, ...",The Journal of Pathology 219,,0,0
Additional Text-Drivernet: uncovering the impact of somatic driver mutations on transcriptional networks in cancer,"A Bashashati, G Haffari, J Ding, G Ha, K Lui, J Rosner, D Huntsman, ...",,,0,0
